TW202146528A - Liquid crystal alignment agent for photo-alignment process, liquid crystal alignment film, and liquid crystal display component which may obtain high liquid crystal alignment by means of a photo-alignment process, and suppress a deviation of in-plane luminance during black display - Google Patents
Liquid crystal alignment agent for photo-alignment process, liquid crystal alignment film, and liquid crystal display component which may obtain high liquid crystal alignment by means of a photo-alignment process, and suppress a deviation of in-plane luminance during black display Download PDFInfo
- Publication number
- TW202146528A TW202146528A TW110110143A TW110110143A TW202146528A TW 202146528 A TW202146528 A TW 202146528A TW 110110143 A TW110110143 A TW 110110143A TW 110110143 A TW110110143 A TW 110110143A TW 202146528 A TW202146528 A TW 202146528A
- Authority
- TW
- Taiwan
- Prior art keywords
- liquid crystal
- group
- repeating unit
- following formula
- crystal alignment
- Prior art date
Links
- 239000004973 liquid crystal related substance Substances 0.000 title claims abstract description 167
- 238000000034 method Methods 0.000 title claims abstract description 57
- 239000003795 chemical substances by application Substances 0.000 title claims abstract description 56
- 125000000962 organic group Chemical group 0.000 claims abstract description 79
- 229920000642 polymer Polymers 0.000 claims abstract description 71
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 50
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 38
- 229920001721 polyimide Polymers 0.000 claims abstract description 32
- 239000004642 Polyimide Substances 0.000 claims abstract description 29
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 24
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical group C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims abstract description 20
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 14
- 125000005843 halogen group Chemical group 0.000 claims abstract description 13
- 239000002243 precursor Substances 0.000 claims abstract description 11
- 235000010290 biphenyl Nutrition 0.000 claims abstract description 10
- 239000004305 biphenyl Substances 0.000 claims abstract description 10
- 125000001153 fluoro group Chemical group F* 0.000 claims abstract description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 8
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 8
- 125000000304 alkynyl group Chemical group 0.000 claims abstract description 8
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 8
- 229910052731 fluorine Inorganic materials 0.000 claims abstract description 8
- 125000001624 naphthyl group Chemical group 0.000 claims abstract description 8
- 239000000758 substrate Substances 0.000 claims description 39
- 238000010304 firing Methods 0.000 claims description 17
- 238000000576 coating method Methods 0.000 claims description 16
- 239000011248 coating agent Substances 0.000 claims description 14
- 238000004519 manufacturing process Methods 0.000 claims description 13
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 5
- 230000001678 irradiating effect Effects 0.000 claims description 4
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 description 53
- 239000010408 film Substances 0.000 description 51
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 42
- 150000004985 diamines Chemical class 0.000 description 25
- 239000000243 solution Substances 0.000 description 24
- 239000002904 solvent Substances 0.000 description 23
- 238000011282 treatment Methods 0.000 description 22
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 18
- 239000002253 acid Substances 0.000 description 16
- -1 cyclic aliphatic tetracarboxylic acid Chemical class 0.000 description 16
- 210000002858 crystal cell Anatomy 0.000 description 13
- 229920005575 poly(amic acid) Polymers 0.000 description 12
- 239000003960 organic solvent Substances 0.000 description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 9
- GTDPSWPPOUPBNX-UHFFFAOYSA-N ac1mqpva Chemical compound CC12C(=O)OC(=O)C1(C)C1(C)C2(C)C(=O)OC1=O GTDPSWPPOUPBNX-UHFFFAOYSA-N 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 229910052757 nitrogen Inorganic materials 0.000 description 9
- RWNUSVWFHDHRCJ-UHFFFAOYSA-N 1-butoxypropan-2-ol Chemical compound CCCCOCC(C)O RWNUSVWFHDHRCJ-UHFFFAOYSA-N 0.000 description 8
- 150000001408 amides Chemical class 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 8
- 239000000565 sealant Substances 0.000 description 8
- 150000000000 tetracarboxylic acids Chemical class 0.000 description 8
- 125000003118 aryl group Chemical group 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 239000011521 glass Substances 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- 125000006158 tetracarboxylic acid group Chemical group 0.000 description 7
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 239000004952 Polyamide Substances 0.000 description 6
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 6
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 6
- 238000001354 calcination Methods 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- SWXVUIWOUIDPGS-UHFFFAOYSA-N diacetone alcohol Chemical compound CC(=O)CC(C)(C)O SWXVUIWOUIDPGS-UHFFFAOYSA-N 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 229920002647 polyamide Polymers 0.000 description 6
- 125000006239 protecting group Chemical group 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000000654 additive Substances 0.000 description 5
- 230000000996 additive effect Effects 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 4
- 125000003504 2-oxazolinyl group Chemical group O1C(=NCC1)* 0.000 description 4
- VATRWWPJWVCZTA-UHFFFAOYSA-N 3-oxo-n-[2-(trifluoromethyl)phenyl]butanamide Chemical compound CC(=O)CC(=O)NC1=CC=CC=C1C(F)(F)F VATRWWPJWVCZTA-UHFFFAOYSA-N 0.000 description 4
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 4
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 4
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical group C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 4
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 4
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 4
- 206010047571 Visual impairment Diseases 0.000 description 4
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 230000005684 electric field Effects 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 125000004433 nitrogen atom Chemical group N* 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- ZFPGARUNNKGOBB-UHFFFAOYSA-N 1-Ethyl-2-pyrrolidinone Chemical compound CCN1CCCC1=O ZFPGARUNNKGOBB-UHFFFAOYSA-N 0.000 description 3
- RRQYJINTUHWNHW-UHFFFAOYSA-N 1-ethoxy-2-(2-ethoxyethoxy)ethane Chemical compound CCOCCOCCOCC RRQYJINTUHWNHW-UHFFFAOYSA-N 0.000 description 3
- HXJZEGBVQCRLOD-UHFFFAOYSA-N 1-triethoxysilylpropan-2-amine Chemical compound CCO[Si](CC(C)N)(OCC)OCC HXJZEGBVQCRLOD-UHFFFAOYSA-N 0.000 description 3
- NQBXSWAWVZHKBZ-UHFFFAOYSA-N 2-butoxyethyl acetate Chemical compound CCCCOCCOC(C)=O NQBXSWAWVZHKBZ-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 3
- 239000004793 Polystyrene Substances 0.000 description 3
- 125000002947 alkylene group Chemical group 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000008033 biological extinction Effects 0.000 description 3
- DKPFZGUDAPQIHT-UHFFFAOYSA-N butyl acetate Chemical compound CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 238000004132 cross linking Methods 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 229940019778 diethylene glycol diethyl ether Drugs 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 229940116333 ethyl lactate Drugs 0.000 description 3
- 238000005227 gel permeation chromatography Methods 0.000 description 3
- 150000002430 hydrocarbons Chemical group 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- ZBKFYXZXZJPWNQ-UHFFFAOYSA-N isothiocyanate group Chemical group [N-]=C=S ZBKFYXZXZJPWNQ-UHFFFAOYSA-N 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 125000003566 oxetanyl group Chemical group 0.000 description 3
- 239000009719 polyimide resin Substances 0.000 description 3
- 229920002223 polystyrene Polymers 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical compound N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 125000006850 spacer group Chemical group 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 239000010409 thin film Substances 0.000 description 3
- FADNCTVVKDWKIX-UHFFFAOYSA-N (2,4-diaminophenyl)methanol Chemical compound NC1=CC=C(CO)C(N)=C1 FADNCTVVKDWKIX-UHFFFAOYSA-N 0.000 description 2
- OHLQBRYVKXJYHZ-UHFFFAOYSA-N (3,5-diaminophenyl)methanol Chemical compound NC1=CC(N)=CC(CO)=C1 OHLQBRYVKXJYHZ-UHFFFAOYSA-N 0.000 description 2
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 2
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 description 2
- LDQMZKBIBRAZEA-UHFFFAOYSA-N 2,4-diaminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C(N)=C1 LDQMZKBIBRAZEA-UHFFFAOYSA-N 0.000 description 2
- FPZWZCWUIYYYBU-UHFFFAOYSA-N 2-(2-ethoxyethoxy)ethyl acetate Chemical compound CCOCCOCCOC(C)=O FPZWZCWUIYYYBU-UHFFFAOYSA-N 0.000 description 2
- PTTPXKJBFFKCEK-UHFFFAOYSA-N 2-Methyl-4-heptanone Chemical compound CC(C)CC(=O)CC(C)C PTTPXKJBFFKCEK-UHFFFAOYSA-N 0.000 description 2
- SZNYYWIUQFZLLT-UHFFFAOYSA-N 2-methyl-1-(2-methylpropoxy)propane Chemical compound CC(C)COCC(C)C SZNYYWIUQFZLLT-UHFFFAOYSA-N 0.000 description 2
- UENRXLSRMCSUSN-UHFFFAOYSA-M 3,5-diaminobenzoate Chemical compound NC1=CC(N)=CC(C([O-])=O)=C1 UENRXLSRMCSUSN-UHFFFAOYSA-M 0.000 description 2
- WFNVGXBEWXBZPL-UHFFFAOYSA-N 3,5-diaminophenol Chemical compound NC1=CC(N)=CC(O)=C1 WFNVGXBEWXBZPL-UHFFFAOYSA-N 0.000 description 2
- QCAHUFWKIQLBNB-UHFFFAOYSA-N 3-(3-methoxypropoxy)propan-1-ol Chemical compound COCCCOCCCO QCAHUFWKIQLBNB-UHFFFAOYSA-N 0.000 description 2
- LVYXPOCADCXMLP-UHFFFAOYSA-N 3-butoxy-n,n-dimethylpropanamide Chemical compound CCCCOCCC(=O)N(C)C LVYXPOCADCXMLP-UHFFFAOYSA-N 0.000 description 2
- LBVMWHCOFMFPEG-UHFFFAOYSA-N 3-methoxy-n,n-dimethylpropanamide Chemical compound COCCC(=O)N(C)C LBVMWHCOFMFPEG-UHFFFAOYSA-N 0.000 description 2
- YBRVSVVVWCFQMG-UHFFFAOYSA-N 4,4'-diaminodiphenylmethane Chemical compound C1=CC(N)=CC=C1CC1=CC=C(N)C=C1 YBRVSVVVWCFQMG-UHFFFAOYSA-N 0.000 description 2
- DPYROBMRMXHROQ-UHFFFAOYSA-N 4,6-diaminobenzene-1,3-diol Chemical compound NC1=CC(N)=C(O)C=C1O DPYROBMRMXHROQ-UHFFFAOYSA-N 0.000 description 2
- HLBLWEWZXPIGSM-UHFFFAOYSA-N 4-Aminophenyl ether Chemical compound C1=CC(N)=CC=C1OC1=CC=C(N)C=C1 HLBLWEWZXPIGSM-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- HXQPUEQDBSPXTE-UHFFFAOYSA-N Diisobutylcarbinol Chemical compound CC(C)CC(O)CC(C)C HXQPUEQDBSPXTE-UHFFFAOYSA-N 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 244000126211 Hericium coralloides Species 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- 239000006087 Silane Coupling Agent Substances 0.000 description 2
- 125000004018 acid anhydride group Chemical group 0.000 description 2
- 125000002723 alicyclic group Chemical group 0.000 description 2
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 2
- XIWMTQIUUWJNRP-UHFFFAOYSA-N amidol Chemical compound NC1=CC=C(O)C(N)=C1 XIWMTQIUUWJNRP-UHFFFAOYSA-N 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 description 2
- ZLSMCQSGRWNEGX-UHFFFAOYSA-N bis(4-aminophenyl)methanone Chemical compound C1=CC(N)=CC=C1C(=O)C1=CC=C(N)C=C1 ZLSMCQSGRWNEGX-UHFFFAOYSA-N 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- BGTOWKSIORTVQH-UHFFFAOYSA-N cyclopentanone Chemical compound O=C1CCCC1 BGTOWKSIORTVQH-UHFFFAOYSA-N 0.000 description 2
- UYAAVKFHBMJOJZ-UHFFFAOYSA-N diimidazo[1,3-b:1',3'-e]pyrazine-5,10-dione Chemical compound O=C1C2=CN=CN2C(=O)C2=CN=CN12 UYAAVKFHBMJOJZ-UHFFFAOYSA-N 0.000 description 2
- BHXIWUJLHYHGSJ-UHFFFAOYSA-N ethyl 3-ethoxypropanoate Chemical compound CCOCCC(=O)OCC BHXIWUJLHYHGSJ-UHFFFAOYSA-N 0.000 description 2
- GAEKPEKOJKCEMS-UHFFFAOYSA-N gamma-valerolactone Chemical compound CC1CCC(=O)O1 GAEKPEKOJKCEMS-UHFFFAOYSA-N 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 125000002883 imidazolyl group Chemical group 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 2
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
- 125000005647 linker group Chemical group 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- WSKHYOXDVZCOJP-UHFFFAOYSA-N naphthalene-1,6-diamine Chemical compound NC1=CC=CC2=CC(N)=CC=C21 WSKHYOXDVZCOJP-UHFFFAOYSA-N 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 125000000466 oxiranyl group Chemical group 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 229940116423 propylene glycol diacetate Drugs 0.000 description 2
- LLHKCFNBLRBOGN-UHFFFAOYSA-N propylene glycol methyl ether acetate Chemical compound COCC(C)OC(C)=O LLHKCFNBLRBOGN-UHFFFAOYSA-N 0.000 description 2
- 125000003373 pyrazinyl group Chemical group 0.000 description 2
- 150000003335 secondary amines Chemical group 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000003512 tertiary amines Chemical group 0.000 description 2
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 2
- WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 description 1
- XIIAYQZJNBULGD-UHFFFAOYSA-N (5alpha)-cholestane Natural products C1CC2CCCCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 XIIAYQZJNBULGD-UHFFFAOYSA-N 0.000 description 1
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 1
- LZDKZFUFMNSQCJ-UHFFFAOYSA-N 1,2-diethoxyethane Chemical compound CCOCCOCC LZDKZFUFMNSQCJ-UHFFFAOYSA-N 0.000 description 1
- CYSGHNMQYZDMIA-UHFFFAOYSA-N 1,3-Dimethyl-2-imidazolidinon Chemical compound CN1CCN(C)C1=O CYSGHNMQYZDMIA-UHFFFAOYSA-N 0.000 description 1
- BWTPUFNHSVZIDT-UHFFFAOYSA-N 1,3-bis[2-(4-aminophenyl)ethyl]urea Chemical compound C1=CC(N)=CC=C1CCNC(=O)NCCC1=CC=C(N)C=C1 BWTPUFNHSVZIDT-UHFFFAOYSA-N 0.000 description 1
- WZCQRUWWHSTZEM-UHFFFAOYSA-N 1,3-phenylenediamine Chemical compound NC1=CC=CC(N)=C1 WZCQRUWWHSTZEM-UHFFFAOYSA-N 0.000 description 1
- ITWBWJFEJCHKSN-UHFFFAOYSA-N 1,4,7-triazonane Chemical compound C1CNCCNCCN1 ITWBWJFEJCHKSN-UHFFFAOYSA-N 0.000 description 1
- GDXHBFHOEYVPED-UHFFFAOYSA-N 1-(2-butoxyethoxy)butane Chemical compound CCCCOCCOCCCC GDXHBFHOEYVPED-UHFFFAOYSA-N 0.000 description 1
- NPMRPDRLIHYOBW-UHFFFAOYSA-N 1-(2-butoxyethoxy)propan-2-ol Chemical compound CCCCOCCOCC(C)O NPMRPDRLIHYOBW-UHFFFAOYSA-N 0.000 description 1
- HUZSCDCNYLZCQH-UHFFFAOYSA-N 1-(2-ethoxyethyl)pyrrolidin-2-one Chemical compound CCOCCN1CCCC1=O HUZSCDCNYLZCQH-UHFFFAOYSA-N 0.000 description 1
- QWOZZTWBWQMEPD-UHFFFAOYSA-N 1-(2-ethoxypropoxy)propan-2-ol Chemical compound CCOC(C)COCC(C)O QWOZZTWBWQMEPD-UHFFFAOYSA-N 0.000 description 1
- OIKFIOGYFGWPAB-UHFFFAOYSA-N 1-(3-methoxypropyl)pyrrolidin-2-one Chemical compound COCCCN1CCCC1=O OIKFIOGYFGWPAB-UHFFFAOYSA-N 0.000 description 1
- BNXZHVUCNYMNOS-UHFFFAOYSA-N 1-butylpyrrolidin-2-one Chemical compound CCCCN1CCCC1=O BNXZHVUCNYMNOS-UHFFFAOYSA-N 0.000 description 1
- NNFAFRAQHBRBCQ-UHFFFAOYSA-N 1-pentylpyrrolidin-2-one Chemical compound CCCCCN1CCCC1=O NNFAFRAQHBRBCQ-UHFFFAOYSA-N 0.000 description 1
- LUVQSCCABURXJL-UHFFFAOYSA-N 1-tert-butylpyrrolidin-2-one Chemical compound CC(C)(C)N1CCCC1=O LUVQSCCABURXJL-UHFFFAOYSA-N 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- WCZNKVPCIFMXEQ-UHFFFAOYSA-N 2,3,5,6-tetramethylbenzene-1,4-diamine Chemical compound CC1=C(C)C(N)=C(C)C(C)=C1N WCZNKVPCIFMXEQ-UHFFFAOYSA-N 0.000 description 1
- KQSMCAVKSJWMSI-UHFFFAOYSA-N 2,4-dimethyl-1-n,1-n,3-n,3-n-tetrakis(oxiran-2-ylmethyl)benzene-1,3-diamine Chemical compound CC1=C(N(CC2OC2)CC2OC2)C(C)=CC=C1N(CC1OC1)CC1CO1 KQSMCAVKSJWMSI-UHFFFAOYSA-N 0.000 description 1
- XVBLEUZLLURXTF-UHFFFAOYSA-N 2,4-dimethylbenzene-1,3-diamine Chemical compound CC1=CC=C(N)C(C)=C1N XVBLEUZLLURXTF-UHFFFAOYSA-N 0.000 description 1
- UONVFNLDGRWLKF-UHFFFAOYSA-N 2,5-diaminobenzoic acid Chemical compound NC1=CC=C(N)C(C(O)=O)=C1 UONVFNLDGRWLKF-UHFFFAOYSA-N 0.000 description 1
- 229940075142 2,5-diaminotoluene Drugs 0.000 description 1
- BWAPJIHJXDYDPW-UHFFFAOYSA-N 2,5-dimethyl-p-phenylenediamine Chemical compound CC1=CC(N)=C(C)C=C1N BWAPJIHJXDYDPW-UHFFFAOYSA-N 0.000 description 1
- RLYCRLGLCUXUPO-UHFFFAOYSA-N 2,6-diaminotoluene Chemical compound CC1=C(N)C=CC=C1N RLYCRLGLCUXUPO-UHFFFAOYSA-N 0.000 description 1
- FDKIPLUTIFGOQS-UHFFFAOYSA-N 2,6-dimethylheptan-4-ol Chemical compound CC(C)CC(CC(C)C)O.C(C(C)C)C(O)CC(C)C FDKIPLUTIFGOQS-UHFFFAOYSA-N 0.000 description 1
- ACUGAGLDFIVSBR-UHFFFAOYSA-N 2,6-dimethylheptan-4-one Chemical compound CC(C)CC(=O)CC(C)C.CC(C)CC(=O)CC(C)C ACUGAGLDFIVSBR-UHFFFAOYSA-N 0.000 description 1
- NLDQNQFPKTYXRS-UHFFFAOYSA-N 2-(2,4-diaminophenoxy)ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOC1=CC=C(N)C=C1N NLDQNQFPKTYXRS-UHFFFAOYSA-N 0.000 description 1
- HOLGXWDGCVTMTB-UHFFFAOYSA-N 2-(2-aminophenyl)aniline Chemical group NC1=CC=CC=C1C1=CC=CC=C1N HOLGXWDGCVTMTB-UHFFFAOYSA-N 0.000 description 1
- XGSQEQCOQAAOHE-UHFFFAOYSA-N 2-(2-butoxyethoxy)propan-1-ol Chemical compound CCCCOCCOC(C)CO XGSQEQCOQAAOHE-UHFFFAOYSA-N 0.000 description 1
- XXXFZKQPYACQLD-UHFFFAOYSA-N 2-(2-hydroxyethoxy)ethyl acetate Chemical compound CC(=O)OCCOCCO XXXFZKQPYACQLD-UHFFFAOYSA-N 0.000 description 1
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- CRQBUNFZJOLMKC-UHFFFAOYSA-N 2-(3-aminophenyl)aniline Chemical group NC1=CC=CC(C=2C(=CC=CC=2)N)=C1 CRQBUNFZJOLMKC-UHFFFAOYSA-N 0.000 description 1
- NCHBYORVPVDWBJ-UHFFFAOYSA-N 2-(3-methylbutoxy)ethanol Chemical compound CC(C)CCOCCO NCHBYORVPVDWBJ-UHFFFAOYSA-N 0.000 description 1
- YCWRFIYBUQBHJI-UHFFFAOYSA-N 2-(4-aminophenyl)acetonitrile Chemical group NC1=CC=C(CC#N)C=C1 YCWRFIYBUQBHJI-UHFFFAOYSA-N 0.000 description 1
- HQLKZWRSOHTERR-UHFFFAOYSA-N 2-Ethylbutyl acetate Chemical compound CCC(CC)COC(C)=O HQLKZWRSOHTERR-UHFFFAOYSA-N 0.000 description 1
- GLUOGZCHYVWCAK-UHFFFAOYSA-N 2-[2-(3-triethoxysilylpropylamino)ethylamino]ethyl acetate Chemical compound CCO[Si](OCC)(OCC)CCCNCCNCCOC(C)=O GLUOGZCHYVWCAK-UHFFFAOYSA-N 0.000 description 1
- JTXMVXSTHSMVQF-UHFFFAOYSA-N 2-acetyloxyethyl acetate Chemical compound CC(=O)OCCOC(C)=O JTXMVXSTHSMVQF-UHFFFAOYSA-N 0.000 description 1
- FZZMTSNZRBFGGU-UHFFFAOYSA-N 2-chloro-7-fluoroquinazolin-4-amine Chemical compound FC1=CC=C2C(N)=NC(Cl)=NC2=C1 FZZMTSNZRBFGGU-UHFFFAOYSA-N 0.000 description 1
- UPGSWASWQBLSKZ-UHFFFAOYSA-N 2-hexoxyethanol Chemical compound CCCCCCOCCO UPGSWASWQBLSKZ-UHFFFAOYSA-N 0.000 description 1
- YEBLAXBYYVCOLT-UHFFFAOYSA-N 2-hydroxy-n,n-dimethylpropanamide Chemical compound CC(O)C(=O)N(C)C YEBLAXBYYVCOLT-UHFFFAOYSA-N 0.000 description 1
- HXDLWJWIAHWIKI-UHFFFAOYSA-N 2-hydroxyethyl acetate Chemical compound CC(=O)OCCO HXDLWJWIAHWIKI-UHFFFAOYSA-N 0.000 description 1
- OBCSAIDCZQSFQH-UHFFFAOYSA-N 2-methyl-1,4-phenylenediamine Chemical compound CC1=CC(N)=CC=C1N OBCSAIDCZQSFQH-UHFFFAOYSA-N 0.000 description 1
- CRWNQZTZTZWPOF-UHFFFAOYSA-N 2-methyl-4-phenylpyridine Chemical compound C1=NC(C)=CC(C=2C=CC=CC=2)=C1 CRWNQZTZTZWPOF-UHFFFAOYSA-N 0.000 description 1
- NUIURNJTPRWVAP-UHFFFAOYSA-N 3,3'-Dimethylbenzidine Chemical group C1=C(N)C(C)=CC(C=2C=C(C)C(N)=CC=2)=C1 NUIURNJTPRWVAP-UHFFFAOYSA-N 0.000 description 1
- UENRXLSRMCSUSN-UHFFFAOYSA-N 3,5-diaminobenzoic acid Chemical compound NC1=CC(N)=CC(C(O)=O)=C1 UENRXLSRMCSUSN-UHFFFAOYSA-N 0.000 description 1
- NDXGRHCEHPFUSU-UHFFFAOYSA-N 3-(3-aminophenyl)aniline Chemical group NC1=CC=CC(C=2C=C(N)C=CC=2)=C1 NDXGRHCEHPFUSU-UHFFFAOYSA-N 0.000 description 1
- ZBMISJGHVWNWTE-UHFFFAOYSA-N 3-(4-aminophenoxy)aniline Chemical compound C1=CC(N)=CC=C1OC1=CC=CC(N)=C1 ZBMISJGHVWNWTE-UHFFFAOYSA-N 0.000 description 1
- GDGWSSXWLLHGGV-UHFFFAOYSA-N 3-(4-aminophenyl)-1,1,3-trimethyl-2h-inden-5-amine Chemical compound C12=CC(N)=CC=C2C(C)(C)CC1(C)C1=CC=C(N)C=C1 GDGWSSXWLLHGGV-UHFFFAOYSA-N 0.000 description 1
- QSPMTSAELLSLOQ-UHFFFAOYSA-N 3-(4-aminophenyl)aniline Chemical group C1=CC(N)=CC=C1C1=CC=CC(N)=C1 QSPMTSAELLSLOQ-UHFFFAOYSA-N 0.000 description 1
- CKOFBUUFHALZGK-UHFFFAOYSA-N 3-[(3-aminophenyl)methyl]aniline Chemical compound NC1=CC=CC(CC=2C=C(N)C=CC=2)=C1 CKOFBUUFHALZGK-UHFFFAOYSA-N 0.000 description 1
- FGWQCROGAHMWSU-UHFFFAOYSA-N 3-[(4-aminophenyl)methyl]aniline Chemical compound C1=CC(N)=CC=C1CC1=CC=CC(N)=C1 FGWQCROGAHMWSU-UHFFFAOYSA-N 0.000 description 1
- HXLAEGYMDGUSBD-UHFFFAOYSA-N 3-[diethoxy(methyl)silyl]propan-1-amine Chemical compound CCO[Si](C)(OCC)CCCN HXLAEGYMDGUSBD-UHFFFAOYSA-N 0.000 description 1
- DOYKFSOCSXVQAN-UHFFFAOYSA-N 3-[diethoxy(methyl)silyl]propyl 2-methylprop-2-enoate Chemical compound CCO[Si](C)(OCC)CCCOC(=O)C(C)=C DOYKFSOCSXVQAN-UHFFFAOYSA-N 0.000 description 1
- IKYAJDOSWUATPI-UHFFFAOYSA-N 3-[dimethoxy(methyl)silyl]propane-1-thiol Chemical compound CO[Si](C)(OC)CCCS IKYAJDOSWUATPI-UHFFFAOYSA-N 0.000 description 1
- LZMNXXQIQIHFGC-UHFFFAOYSA-N 3-[dimethoxy(methyl)silyl]propyl 2-methylprop-2-enoate Chemical compound CO[Si](C)(OC)CCCOC(=O)C(C)=C LZMNXXQIQIHFGC-UHFFFAOYSA-N 0.000 description 1
- GALUFHRFAYTRDG-UHFFFAOYSA-N 3-ethoxybutyl acetate Chemical compound CCOC(C)CCOC(C)=O GALUFHRFAYTRDG-UHFFFAOYSA-N 0.000 description 1
- CRORGGSWAKIXSA-UHFFFAOYSA-N 3-methylbutyl 2-hydroxypropanoate Chemical compound CC(C)CCOC(=O)C(C)O CRORGGSWAKIXSA-UHFFFAOYSA-N 0.000 description 1
- URDOJQUSEUXVRP-UHFFFAOYSA-N 3-triethoxysilylpropyl 2-methylprop-2-enoate Chemical compound CCO[Si](OCC)(OCC)CCCOC(=O)C(C)=C URDOJQUSEUXVRP-UHFFFAOYSA-N 0.000 description 1
- LVNLBBGBASVLLI-UHFFFAOYSA-N 3-triethoxysilylpropylurea Chemical compound CCO[Si](OCC)(OCC)CCCNC(N)=O LVNLBBGBASVLLI-UHFFFAOYSA-N 0.000 description 1
- SJECZPVISLOESU-UHFFFAOYSA-N 3-trimethoxysilylpropan-1-amine Chemical compound CO[Si](OC)(OC)CCCN SJECZPVISLOESU-UHFFFAOYSA-N 0.000 description 1
- UUEWCQRISZBELL-UHFFFAOYSA-N 3-trimethoxysilylpropane-1-thiol Chemical compound CO[Si](OC)(OC)CCCS UUEWCQRISZBELL-UHFFFAOYSA-N 0.000 description 1
- XDLMVUHYZWKMMD-UHFFFAOYSA-N 3-trimethoxysilylpropyl 2-methylprop-2-enoate Chemical compound CO[Si](OC)(OC)CCCOC(=O)C(C)=C XDLMVUHYZWKMMD-UHFFFAOYSA-N 0.000 description 1
- KBQVDAIIQCXKPI-UHFFFAOYSA-N 3-trimethoxysilylpropyl prop-2-enoate Chemical compound CO[Si](OC)(OC)CCCOC(=O)C=C KBQVDAIIQCXKPI-UHFFFAOYSA-N 0.000 description 1
- LVACOMKKELLCHJ-UHFFFAOYSA-N 3-trimethoxysilylpropylurea Chemical compound CO[Si](OC)(OC)CCCNC(N)=O LVACOMKKELLCHJ-UHFFFAOYSA-N 0.000 description 1
- KQIKKETXZQDHGE-FOCLMDBBSA-N 4,4'-diaminoazobenzene Chemical compound C1=CC(N)=CC=C1\N=N\C1=CC=C(N)C=C1 KQIKKETXZQDHGE-FOCLMDBBSA-N 0.000 description 1
- LNPMZQXEPNWCMG-UHFFFAOYSA-N 4-(2-aminoethyl)aniline Chemical compound NCCC1=CC=C(N)C=C1 LNPMZQXEPNWCMG-UHFFFAOYSA-N 0.000 description 1
- LVNPGQZSPDFZNC-UHFFFAOYSA-N 4-(4-amino-3-fluorophenyl)-2-fluoroaniline Chemical group C1=C(F)C(N)=CC=C1C1=CC=C(N)C(F)=C1 LVNPGQZSPDFZNC-UHFFFAOYSA-N 0.000 description 1
- NNIPOYNUFNLQMO-UHFFFAOYSA-N 4-[2-(methylamino)ethyl]aniline Chemical compound CNCCC1=CC=C(N)C=C1 NNIPOYNUFNLQMO-UHFFFAOYSA-N 0.000 description 1
- WUPRYUDHUFLKFL-UHFFFAOYSA-N 4-[3-(4-aminophenoxy)phenoxy]aniline Chemical compound C1=CC(N)=CC=C1OC1=CC=CC(OC=2C=CC(N)=CC=2)=C1 WUPRYUDHUFLKFL-UHFFFAOYSA-N 0.000 description 1
- BOVVHULZWVFIOX-UHFFFAOYSA-N 4-[3-(4-aminophenyl)phenyl]aniline Chemical compound C1=CC(N)=CC=C1C1=CC=CC(C=2C=CC(N)=CC=2)=C1 BOVVHULZWVFIOX-UHFFFAOYSA-N 0.000 description 1
- JCRRFJIVUPSNTA-UHFFFAOYSA-N 4-[4-(4-aminophenoxy)phenoxy]aniline Chemical compound C1=CC(N)=CC=C1OC(C=C1)=CC=C1OC1=CC=C(N)C=C1 JCRRFJIVUPSNTA-UHFFFAOYSA-N 0.000 description 1
- NRHZAVJNUJCQRL-UHFFFAOYSA-N 4-[4-(4-aminophenyl)piperazin-1-yl]aniline Chemical compound C1=CC(N)=CC=C1N1CCN(C=2C=CC(N)=CC=2)CC1 NRHZAVJNUJCQRL-UHFFFAOYSA-N 0.000 description 1
- PJWQLRKRVISYPL-UHFFFAOYSA-N 4-[4-amino-3-(trifluoromethyl)phenyl]-2-(trifluoromethyl)aniline Chemical group C1=C(C(F)(F)F)C(N)=CC=C1C1=CC=C(N)C(C(F)(F)F)=C1 PJWQLRKRVISYPL-UHFFFAOYSA-N 0.000 description 1
- PBPYNPXJEIOCEL-UHFFFAOYSA-N 4-[[4-[(4-aminophenyl)methyl]phenyl]methyl]aniline Chemical compound C1=CC(N)=CC=C1CC(C=C1)=CC=C1CC1=CC=C(N)C=C1 PBPYNPXJEIOCEL-UHFFFAOYSA-N 0.000 description 1
- FAUAZXVRLVIARB-UHFFFAOYSA-N 4-[[4-[bis(oxiran-2-ylmethyl)amino]phenyl]methyl]-n,n-bis(oxiran-2-ylmethyl)aniline Chemical compound C1OC1CN(C=1C=CC(CC=2C=CC(=CC=2)N(CC2OC2)CC2OC2)=CC=1)CC1CO1 FAUAZXVRLVIARB-UHFFFAOYSA-N 0.000 description 1
- CNPURSDMOWDNOQ-UHFFFAOYSA-N 4-methoxy-7h-pyrrolo[2,3-d]pyrimidin-2-amine Chemical group COC1=NC(N)=NC2=C1C=CN2 CNPURSDMOWDNOQ-UHFFFAOYSA-N 0.000 description 1
- LBNFPUAJWZYIOQ-UHFFFAOYSA-N 4-n-(4-aminophenyl)-4-n-methylbenzene-1,4-diamine Chemical compound C=1C=C(N)C=CC=1N(C)C1=CC=C(N)C=C1 LBNFPUAJWZYIOQ-UHFFFAOYSA-N 0.000 description 1
- QZHXKQKKEBXYRG-UHFFFAOYSA-N 4-n-(4-aminophenyl)benzene-1,4-diamine Chemical compound C1=CC(N)=CC=C1NC1=CC=C(N)C=C1 QZHXKQKKEBXYRG-UHFFFAOYSA-N 0.000 description 1
- UHIXFUMVHZAVGP-UHFFFAOYSA-N 4-n-[4-[4-(4-amino-n-methylanilino)phenyl]phenyl]-4-n-methylbenzene-1,4-diamine Chemical compound C=1C=C(C=2C=CC(=CC=2)N(C)C=2C=CC(N)=CC=2)C=CC=1N(C)C1=CC=C(N)C=C1 UHIXFUMVHZAVGP-UHFFFAOYSA-N 0.000 description 1
- QPDNZLWPWXPPIO-UHFFFAOYSA-N 4-n-[4-[4-(4-aminoanilino)phenyl]phenyl]benzene-1,4-diamine Chemical compound C1=CC(N)=CC=C1NC1=CC=C(C=2C=CC(NC=3C=CC(N)=CC=3)=CC=2)C=C1 QPDNZLWPWXPPIO-UHFFFAOYSA-N 0.000 description 1
- WXAIEIRYBSKHDP-UHFFFAOYSA-N 4-phenyl-n-(4-phenylphenyl)-n-[4-[4-(4-phenyl-n-(4-phenylphenyl)anilino)phenyl]phenyl]aniline Chemical compound C1=CC=CC=C1C1=CC=C(N(C=2C=CC(=CC=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)C=2C=CC(=CC=2)N(C=2C=CC(=CC=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)C=2C=CC=CC=2)C=C1 WXAIEIRYBSKHDP-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- LPEKGGXMPWTOCB-UHFFFAOYSA-N 8beta-(2,3-epoxy-2-methylbutyryloxy)-14-acetoxytithifolin Natural products COC(=O)C(C)O LPEKGGXMPWTOCB-UHFFFAOYSA-N 0.000 description 1
- VYQYKCAZJQOVJO-UHFFFAOYSA-N 9-ethylcarbazole-3,6-diamine Chemical compound NC1=CC=C2N(CC)C3=CC=C(N)C=C3C2=C1 VYQYKCAZJQOVJO-UHFFFAOYSA-N 0.000 description 1
- KPIAHQAOODFLBZ-UHFFFAOYSA-N 9-methylcarbazole-3,6-diamine Chemical compound NC1=CC=C2N(C)C3=CC=C(N)C=C3C2=C1 KPIAHQAOODFLBZ-UHFFFAOYSA-N 0.000 description 1
- NKSQIEJTEVJKKB-UHFFFAOYSA-N 9-phenylcarbazole-3,6-diamine Chemical compound C12=CC=C(N)C=C2C2=CC(N)=CC=C2N1C1=CC=CC=C1 NKSQIEJTEVJKKB-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- MRABAEUHTLLEML-UHFFFAOYSA-N Butyl lactate Chemical compound CCCCOC(=O)C(C)O MRABAEUHTLLEML-UHFFFAOYSA-N 0.000 description 1
- PYXOOYCCHHAQDD-UHFFFAOYSA-N C(C)O[SiH3].C1(=CC=CC=C1)NCCC[Si](OC)(OC)OC Chemical compound C(C)O[SiH3].C1(=CC=CC=C1)NCCC[Si](OC)(OC)OC PYXOOYCCHHAQDD-UHFFFAOYSA-N 0.000 description 1
- BVUGVABZFPUCSW-UHFFFAOYSA-N C1=CC=CC=C1.COC=1C=C(C=CC1N)C1=CC(=C(C=C1)N)OC Chemical compound C1=CC=CC=C1.COC=1C=C(C=CC1N)C1=CC(=C(C=C1)N)OC BVUGVABZFPUCSW-UHFFFAOYSA-N 0.000 description 1
- HLUOZTYRNHMSON-UHFFFAOYSA-N COCCCCN1C(CCC1)=O Chemical compound COCCCCN1C(CCC1)=O HLUOZTYRNHMSON-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- YYLLIJHXUHJATK-UHFFFAOYSA-N Cyclohexyl acetate Chemical compound CC(=O)OC1CCCCC1 YYLLIJHXUHJATK-UHFFFAOYSA-N 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical group COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- KMTRUDSVKNLOMY-UHFFFAOYSA-N Ethylene carbonate Chemical compound O=C1OCCO1 KMTRUDSVKNLOMY-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical group C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 229930182556 Polyacetal Natural products 0.000 description 1
- 229920002396 Polyurea Polymers 0.000 description 1
- WDVSHHCDHLJJJR-UHFFFAOYSA-N Proflavine Chemical compound C1=CC(N)=CC2=NC3=CC(N)=CC=C3C=C21 WDVSHHCDHLJJJR-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 1
- 229910052581 Si3N4 Inorganic materials 0.000 description 1
- 229910004298 SiO 2 Inorganic materials 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 229910010413 TiO 2 Inorganic materials 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 125000000641 acridinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3C=C12)* 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 125000002015 acyclic group Chemical group 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- OYTKINVCDFNREN-UHFFFAOYSA-N amifampridine Chemical compound NC1=CC=NC=C1N OYTKINVCDFNREN-UHFFFAOYSA-N 0.000 description 1
- 229960004012 amifampridine Drugs 0.000 description 1
- 229940072049 amyl acetate Drugs 0.000 description 1
- PGMYKACGEOXYJE-UHFFFAOYSA-N anhydrous amyl acetate Natural products CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 150000004984 aromatic diamines Chemical class 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- ZSIQJIWKELUFRJ-UHFFFAOYSA-N azepane Chemical compound C1CCCNCC1 ZSIQJIWKELUFRJ-UHFFFAOYSA-N 0.000 description 1
- DMLAVOWQYNRWNQ-UHFFFAOYSA-N azobenzene Chemical compound C1=CC=CC=C1N=NC1=CC=CC=C1 DMLAVOWQYNRWNQ-UHFFFAOYSA-N 0.000 description 1
- HFACYLZERDEVSX-UHFFFAOYSA-N benzidine Chemical group C1=CC(N)=CC=C1C1=CC=C(N)C=C1 HFACYLZERDEVSX-UHFFFAOYSA-N 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- RRIRSNXZGJWTQM-UHFFFAOYSA-N butyl 3-methoxypropanoate Chemical compound CCCCOC(=O)CCOC RRIRSNXZGJWTQM-UHFFFAOYSA-N 0.000 description 1
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- XIIAYQZJNBULGD-LDHZKLTISA-N cholestane Chemical compound C1CC2CCCC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 XIIAYQZJNBULGD-LDHZKLTISA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000004643 cyanate ester Substances 0.000 description 1
- 150000005676 cyclic carbonates Chemical group 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 125000006159 dianhydride group Chemical group 0.000 description 1
- OTARVPUIYXHRRB-UHFFFAOYSA-N diethoxy-methyl-[3-(oxiran-2-ylmethoxy)propyl]silane Chemical compound CCO[Si](C)(OCC)CCCOCC1CO1 OTARVPUIYXHRRB-UHFFFAOYSA-N 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- WHGNXNCOTZPEEK-UHFFFAOYSA-N dimethoxy-methyl-[3-(oxiran-2-ylmethoxy)propyl]silane Chemical compound CO[Si](C)(OC)CCCOCC1CO1 WHGNXNCOTZPEEK-UHFFFAOYSA-N 0.000 description 1
- BDUPRNVPXOHWIL-UHFFFAOYSA-N dimethyl sulfite Chemical class COS(=O)OC BDUPRNVPXOHWIL-UHFFFAOYSA-N 0.000 description 1
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- ODQWQRRAPPTVAG-GZTJUZNOSA-N doxepin Chemical compound C1OC2=CC=CC=C2C(=C/CCN(C)C)/C2=CC=CC=C21 ODQWQRRAPPTVAG-GZTJUZNOSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- FWDBOZPQNFPOLF-UHFFFAOYSA-N ethenyl(triethoxy)silane Chemical compound CCO[Si](OCC)(OCC)C=C FWDBOZPQNFPOLF-UHFFFAOYSA-N 0.000 description 1
- NKSJNEHGWDZZQF-UHFFFAOYSA-N ethenyl(trimethoxy)silane Chemical compound CO[Si](OC)(OC)C=C NKSJNEHGWDZZQF-UHFFFAOYSA-N 0.000 description 1
- IJUHLFUALMUWOM-UHFFFAOYSA-N ethyl 3-methoxypropanoate Chemical compound CCOC(=O)CCOC IJUHLFUALMUWOM-UHFFFAOYSA-N 0.000 description 1
- CNEKKZXYBHKSDC-UHFFFAOYSA-N ethyl acetate;propane-1,2-diol Chemical compound CC(O)CO.CCOC(C)=O CNEKKZXYBHKSDC-UHFFFAOYSA-N 0.000 description 1
- MVUXVDIFQSGECB-UHFFFAOYSA-N ethyl n-(3-triethoxysilylpropyl)carbamate Chemical compound CCOC(=O)NCCC[Si](OCC)(OCC)OCC MVUXVDIFQSGECB-UHFFFAOYSA-N 0.000 description 1
- MHBPZEDIFIPGSX-UHFFFAOYSA-N ethyl n-(3-trimethoxysilylpropyl)carbamate Chemical compound CCOC(=O)NCCC[Si](OC)(OC)OC MHBPZEDIFIPGSX-UHFFFAOYSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-M hexanoate Chemical compound CCCCCC([O-])=O FUZZWVXGSFPDMH-UHFFFAOYSA-M 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 150000003949 imides Chemical class 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229940018564 m-phenylenediamine Drugs 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- GXHFUVWIGNLZSC-UHFFFAOYSA-N meldrum's acid Chemical group CC1(C)OC(=O)CC(=O)O1 GXHFUVWIGNLZSC-UHFFFAOYSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000006109 methionine Nutrition 0.000 description 1
- BDJSOPWXYLFTNW-UHFFFAOYSA-N methyl 3-methoxypropanoate Chemical compound COCCC(=O)OC BDJSOPWXYLFTNW-UHFFFAOYSA-N 0.000 description 1
- 229940057867 methyl lactate Drugs 0.000 description 1
- ACXIAEKDVUJRSK-UHFFFAOYSA-N methyl(silyloxy)silane Chemical compound C[SiH2]O[SiH3] ACXIAEKDVUJRSK-UHFFFAOYSA-N 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- PHQOGHDTIVQXHL-UHFFFAOYSA-N n'-(3-trimethoxysilylpropyl)ethane-1,2-diamine Chemical compound CO[Si](OC)(OC)CCCNCCN PHQOGHDTIVQXHL-UHFFFAOYSA-N 0.000 description 1
- VNRDAMBPFDPXSM-UHFFFAOYSA-N n'-[2-(3-triethoxysilylpropylamino)ethyl]ethane-1,2-diamine Chemical compound CCO[Si](OCC)(OCC)CCCNCCNCCN VNRDAMBPFDPXSM-UHFFFAOYSA-N 0.000 description 1
- NHBRUUFBSBSTHM-UHFFFAOYSA-N n'-[2-(3-trimethoxysilylpropylamino)ethyl]ethane-1,2-diamine Chemical compound CO[Si](OC)(OC)CCCNCCNCCN NHBRUUFBSBSTHM-UHFFFAOYSA-N 0.000 description 1
- KBJFYLLAMSZSOG-UHFFFAOYSA-N n-(3-trimethoxysilylpropyl)aniline Chemical compound CO[Si](OC)(OC)CCCNC1=CC=CC=C1 KBJFYLLAMSZSOG-UHFFFAOYSA-N 0.000 description 1
- YKYONYBAUNKHLG-UHFFFAOYSA-N n-Propyl acetate Natural products CCCOC(C)=O YKYONYBAUNKHLG-UHFFFAOYSA-N 0.000 description 1
- ILRLVKWBBFWKTN-UHFFFAOYSA-N n-benzyl-3-triethoxysilylpropan-1-amine Chemical compound CCO[Si](OCC)(OCC)CCCNCC1=CC=CC=C1 ILRLVKWBBFWKTN-UHFFFAOYSA-N 0.000 description 1
- CLYWMXVFAMGARU-UHFFFAOYSA-N n-benzyl-3-trimethoxysilylpropan-1-amine Chemical compound CO[Si](OC)(OC)CCCNCC1=CC=CC=C1 CLYWMXVFAMGARU-UHFFFAOYSA-N 0.000 description 1
- 229940017144 n-butyl lactate Drugs 0.000 description 1
- PZYDAVFRVJXFHS-UHFFFAOYSA-N n-cyclohexyl-2-pyrrolidone Chemical compound O=C1CCCN1C1CCCCC1 PZYDAVFRVJXFHS-UHFFFAOYSA-N 0.000 description 1
- KQSABULTKYLFEV-UHFFFAOYSA-N naphthalene-1,5-diamine Chemical compound C1=CC=C2C(N)=CC=CC2=C1N KQSABULTKYLFEV-UHFFFAOYSA-N 0.000 description 1
- ZDWYJINCYGEEJB-UHFFFAOYSA-N naphthalene-1,7-diamine Chemical compound C1=CC=C(N)C2=CC(N)=CC=C21 ZDWYJINCYGEEJB-UHFFFAOYSA-N 0.000 description 1
- GOGZBMRXLADNEV-UHFFFAOYSA-N naphthalene-2,6-diamine Chemical compound C1=C(N)C=CC2=CC(N)=CC=C21 GOGZBMRXLADNEV-UHFFFAOYSA-N 0.000 description 1
- HBJPJUGOYJOSLR-UHFFFAOYSA-N naphthalene-2,7-diamine Chemical compound C1=CC(N)=CC2=CC(N)=CC=C21 HBJPJUGOYJOSLR-UHFFFAOYSA-N 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 238000007645 offset printing Methods 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 238000007699 photoisomerization reaction Methods 0.000 description 1
- 238000006303 photolysis reaction Methods 0.000 description 1
- LFSXCDWNBUNEEM-UHFFFAOYSA-N phthalazine Chemical compound C1=NN=CC2=CC=CC=C21 LFSXCDWNBUNEEM-UHFFFAOYSA-N 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 238000006068 polycondensation reaction Methods 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- JCMFJIHDWDKYIL-UHFFFAOYSA-N propyl 3-methoxypropanoate Chemical compound CCCOC(=O)CCOC JCMFJIHDWDKYIL-UHFFFAOYSA-N 0.000 description 1
- 229940090181 propyl acetate Drugs 0.000 description 1
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 1
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- VHNQIURBCCNWDN-UHFFFAOYSA-N pyridine-2,6-diamine Chemical compound NC1=CC=CC(N)=N1 VHNQIURBCCNWDN-UHFFFAOYSA-N 0.000 description 1
- YAAWASYJIRZXSZ-UHFFFAOYSA-N pyrimidine-2,4-diamine Chemical compound NC1=CC=NC(N)=N1 YAAWASYJIRZXSZ-UHFFFAOYSA-N 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000006798 ring closing metathesis reaction Methods 0.000 description 1
- 238000007650 screen-printing Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 description 1
- 238000003980 solgel method Methods 0.000 description 1
- 238000004528 spin coating Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 150000003431 steroids Chemical group 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- FRGPKMWIYVTFIQ-UHFFFAOYSA-N triethoxy(3-isocyanatopropyl)silane Chemical compound CCO[Si](OCC)(OCC)CCCN=C=O FRGPKMWIYVTFIQ-UHFFFAOYSA-N 0.000 description 1
- JXUKBNICSRJFAP-UHFFFAOYSA-N triethoxy-[3-(oxiran-2-ylmethoxy)propyl]silane Chemical compound CCO[Si](OCC)(OCC)CCCOCC1CO1 JXUKBNICSRJFAP-UHFFFAOYSA-N 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- HQYALQRYBUJWDH-UHFFFAOYSA-N trimethoxy(propyl)silane Chemical compound CCC[Si](OC)(OC)OC HQYALQRYBUJWDH-UHFFFAOYSA-N 0.000 description 1
- DQZNLOXENNXVAD-UHFFFAOYSA-N trimethoxy-[2-(7-oxabicyclo[4.1.0]heptan-4-yl)ethyl]silane Chemical compound C1C(CC[Si](OC)(OC)OC)CCC2OC21 DQZNLOXENNXVAD-UHFFFAOYSA-N 0.000 description 1
- BPSIOYPQMFLKFR-UHFFFAOYSA-N trimethoxy-[3-(oxiran-2-ylmethoxy)propyl]silane Chemical compound CO[Si](OC)(OC)CCCOCC1CO1 BPSIOYPQMFLKFR-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000011077 uniformity evaluation Methods 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
- C08G73/1042—Copolyimides derived from at least two different tetracarboxylic compounds or two different diamino compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
- C08G73/1046—Polyimides containing oxygen in the form of ether bonds in the main chain
- C08G73/105—Polyimides containing oxygen in the form of ether bonds in the main chain with oxygen only in the diamino moiety
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/133—Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
- G02F1/1333—Constructional arrangements; Manufacturing methods
- G02F1/1337—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/133—Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
- G02F1/1333—Constructional arrangements; Manufacturing methods
- G02F1/1337—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
- G02F1/133711—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
- G02F1/133723—Polyimide, polyamide-imide
Landscapes
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Nonlinear Science (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Mathematical Physics (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Abstract
本發明的課題為提供可藉由光配向法得到具有高的液晶配向性,抑制了黑顯示時於面內之亮度的偏差,且對比經提高之液晶顯示元件的光配向法用液晶配向劑。 其解決手段為一種光配向法用液晶配向劑,其含有選自由聚醯亞胺前驅物及其醯亞胺化聚合物所成之群的至少1種聚合物(A),該聚合物(A)具有 選自由下述式(1-a)表示之重複單位及下述式(1-i)表示之重複單位所成之群的至少1種重複單位(a1),與 選自由下述式(2-a)表示之重複單位及下述式(2-i)表示之重複單位所成之群的至少1種重複單位(a2),且含有全部重複單位之1~20莫耳%的前述重複單位(a1)。 (式中,X1 表示以下述式(B)表示之4價有機基,X2 表示以下述式(C)表示之4價有機基。R、Z係分別獨立地表示氫原子或碳數1~6之烷基。複數個R及Z,各自可相同亦可相異。Y1 、Y2 係分別獨立地表示以下述式(O)表示之2價有機基)。 (式中,Rb1 ~Rb4 係分別獨立地表示氫原子、鹵素原子,或碳數1~6之烷基。L1 表示單鍵、-CH2 -、-(CH2 )n -(n為2~18之整數),或前述-(CH2 )n -之-CH2 -的至少一部分經 -O-、-C(=O)-或-O-C(=O)-之任一者取代之基。Rc1 ~Rc4 係分別獨立地表示氫原子、鹵素原子、碳數1~6之烷基、碳數2~6之烯基、碳數2~6之炔基、含有氟原子之碳數1~6之1價有機基,或苯基,Rc1 ~Rc4 之至少一者表示上述定義中的氫原子以外之基)。 (Ar表示苯環、聯苯結構,或萘環,2個Ar可相同亦可相異,環上的任意氫原子亦可經1價有機基取代。Q2 表示 -CH2 -、-(CH2 )n -(n為2~18之整數),或前述-(CH2 )n -之-CH2 -的至少一部分經-O-、-C(=O)-或-O-C(=O)-之任一者取代之基。p為0或1之整數。惟,p為0時,Ar表示聯苯結構,p為1時,2個Ar之至少一者表示萘環。*表示鍵結部位)。The subject of the present invention is to provide a liquid crystal aligning agent for photo-alignment that can obtain high liquid crystal alignment by photo-alignment, suppresses the variation in in-plane luminance during black display, and compares an improved liquid crystal display element. The solution is a liquid crystal alignment agent for a photo-alignment method, which contains at least one polymer (A) selected from the group consisting of polyimide precursors and imidized polymers thereof, the polymer (A) ) has at least one repeating unit (a1) selected from the group consisting of the repeating unit represented by the following formula (1-a) and the repeating unit represented by the following formula (1-i), and is selected from the following formula ( At least one repeating unit (a2) of the group consisting of the repeating unit represented by 2-a) and the repeating unit represented by the following formula (2-i), and containing 1 to 20 mol% of the aforementioned repeats of all repeating units unit (a1). (wherein, X 1 represents a tetravalent organic group represented by the following formula (B), and X 2 represents a tetravalent organic group represented by the following formula (C). R and Z each independently represent a hydrogen atom or a carbon number of 1 An alkyl group of ~6. A plurality of R and Z may be the same or different from each other. Y 1 and Y 2 each independently represent a divalent organic group represented by the following formula (O). (In the formula, R b1 to R b4 each independently represent a hydrogen atom, a halogen atom, or an alkyl group having 1 to 6 carbon atoms. L 1 represents a single bond, -CH 2 -, -(CH 2 ) n -(n is an integer from 2 to 18), or at least a part of -CH 2 - of the aforementioned -(CH 2 ) n - is substituted by any one of -O-, -C(=O)- or -OC(=O)- R c1 to R c4 independently represent a hydrogen atom, a halogen atom, an alkyl group with 1 to 6 carbon atoms, an alkenyl group with 2 to 6 carbon atoms, an alkynyl group with 2 to 6 carbon atoms, and a fluorine atom-containing group. A monovalent organic group having 1 to 6 carbon atoms, or a phenyl group, and at least one of R c1 to R c4 represents a group other than a hydrogen atom in the above definition). (Ar represents a benzene ring, a biphenyl structure, or a naphthalene ring, the two Ars can be the same or different, and any hydrogen atom on the ring can also be substituted by a monovalent organic group. Q 2 represents -CH 2 -, -(CH 2 ) n - (n is an integer of 2 to 18), or at least a part of -CH 2 - of the aforementioned -(CH 2 ) n - is processed by -O-, -C(=O)- or -OC(=O) A group substituted by any of -. p is an integer of 0 or 1. However, when p is 0, Ar represents a biphenyl structure, and when p is 1, at least one of the two Ars represents a naphthalene ring. * represents a bond part).
Description
本發明係關於光配向法用液晶配向劑、液晶配向膜,及液晶顯示元件。The present invention relates to a liquid crystal alignment agent for a photo-alignment method, a liquid crystal alignment film, and a liquid crystal display element.
自以往起,液晶顯示裝置,係廣為使用作為個人電腦、智慧型手機、行動電話、電視接收器等之顯示部。液晶顯示裝置,例如具備被夾持於元件基板與彩色濾光片基板之間的液晶層、對液晶層施加電場之畫素電極及共同電極、控制液晶層之液晶分子的配向性之配向膜、切換供給於畫素電極之電氣信號的薄膜電晶體(TFT)等。作為液晶分子之驅動方式,已知有TN(Twisted Nematic)方式、VA(Vertical Alignment)方式等之縱電場方式,或IPS (In Plane Switching)方式、FFS(Fringe Field Switching)方式等之橫電場方式。From the past, liquid crystal display devices have been widely used as display parts of personal computers, smart phones, mobile phones, television receivers, and the like. The liquid crystal display device includes, for example, a liquid crystal layer sandwiched between an element substrate and a color filter substrate, a pixel electrode and a common electrode for applying an electric field to the liquid crystal layer, an alignment film for controlling the alignment of liquid crystal molecules in the liquid crystal layer, Thin-film transistors (TFTs), etc. that switch electrical signals supplied to pixel electrodes. As a driving method of liquid crystal molecules, a vertical electric field method such as a TN (Twisted Nematic) method and a VA (Vertical Alignment) method, and a transverse electric field method such as an IPS (In Plane Switching) method and a FFS (Fringe Field Switching) method are known. .
目前,工業上最為普及的液晶配向膜,係藉由進行將形成於電極基板上之包含聚醯胺酸及/或將其醯亞胺化而得之聚醯亞胺的膜之表面,以綿、耐綸、聚酯等之布朝一方向摩擦的所謂摩擦處理來製作。摩擦處理,為簡便且生產性優良的工業上有用的方法。但是,伴隨液晶顯示元件之高性能化、高精細化、大型化,因摩擦處理所產生之配向膜表面的傷痕、產生灰塵、機械力或靜電所致之影響、進而配向處理面內之不均勻性等之各種問題變得明顯。作為取代摩擦處理之配向處理方法,已知有藉由照射經偏光的放射線,而賦予液晶配向能力之光配向法。光配向法,提出有利用光異構化反應者、利用光交聯反應者、利用光分解反應者等(參照非專利文獻1、專利文獻1)。At present, the most popular liquid crystal alignment film in the industry is a surface of a film formed on the electrode substrate containing polyimide and/or polyimide obtained by imidizing it, with a , Nylon, polyester and other fabrics are rubbed in one direction so-called rubbing treatment. The rubbing treatment is an industrially useful method that is simple and excellent in productivity. However, with the increase in performance, high definition, and size of liquid crystal display elements, scratches on the surface of the alignment film caused by rubbing treatment, the generation of dust, the influence of mechanical force or static electricity, and the unevenness in the alignment treatment surface Issues such as sex become apparent. As an alignment treatment method in place of the rubbing treatment, a photo-alignment method for imparting alignment ability to a liquid crystal by irradiating polarized radiation is known. As the photoalignment method, those utilizing a photoisomerization reaction, a photocrosslinking reaction, and a photolysis reaction have been proposed (see Non-Patent Document 1 and Patent Document 1).
液晶顯示元件之構成構件的液晶配向膜,為用以使液晶均勻排列之膜,液晶配向性為重要特性之一。但是,以前述光配向法所得之液晶配向膜,相較於由以往之摩擦處理所得之液晶配向膜,液晶配向性有變低的傾向,具備該液晶配向膜之液晶顯示裝置之適用範圍受限。 [先前技術文獻] [專利文獻]A liquid crystal alignment film, which is a constituent member of a liquid crystal display element, is a film for aligning liquid crystals uniformly, and liquid crystal alignment is one of the important characteristics. However, compared with the liquid crystal alignment film obtained by the conventional rubbing treatment, the liquid crystal alignment film obtained by the aforementioned photo-alignment method tends to have a lower liquid crystal alignment, and the application scope of the liquid crystal display device provided with the liquid crystal alignment film is limited. . [Prior Art Literature] [Patent Literature]
[專利文獻1]日本特開平9-297313號公報 [非專利文獻][Patent Document 1] Japanese Patent Application Laid-Open No. 9-297313 [Non-patent literature]
[非專利文獻1]「功能材料」、1997年11月號、Vol.17、No.11、13~22頁[Non-Patent Document 1] "Functional Materials", November 1997, Vol. 17, No. 11, pp. 13-22
[發明所欲解決之課題][The problem to be solved by the invention]
又,實際之液晶顯示元件中,因製造上之偏差等,於液晶顯示元件面內,液晶之扭轉角度有些微偏差。如此一來,起因於如此的面內偏差,於液晶顯示元件中,黑顯示時之亮度係於面內有偏差。 本發明係有鑑於上述實情而為者,其目的之一為提供可藉由光配向法得到具有高的液晶配向性,抑制了黑顯示時於面內的亮度偏差,且對比經提高的液晶顯示元件之光配向法用液晶配向劑。 [用以解決課題之手段]Furthermore, in an actual liquid crystal display element, the twist angle of the liquid crystal slightly varies within the surface of the liquid crystal display element due to variations in manufacturing and the like. In this way, due to such an in-plane variation, in a liquid crystal display element, the luminance at the time of black display varies within the plane. The present invention has been made in view of the above-mentioned facts, and one of its objectives is to provide a liquid crystal display with high liquid crystal alignment that can be obtained by a photo-alignment method, suppressing in-plane luminance variation during black display, and having an improved contrast ratio Liquid crystal alignment agent for photo-alignment of components. [means to solve the problem]
本發明者進行深入研究後,發現藉由使用含有特定成分之液晶配向劑,可解決上述課題,而完成本發明。具體而言係以下述為要旨者。The inventors of the present invention have found that the above-mentioned problems can be solved by using a liquid crystal aligning agent containing a specific component, and have completed the present invention. Specifically, the gist is as follows.
一種光配向法用液晶配向劑,其特徵為含有選自由聚醯亞胺前驅物及其醯亞胺化聚合物所成之群的至少1種聚合物(A),該聚合物(A)具有 選自由下述式(1-a)表示之重複單位及下述式(1-i)表示之重複單位所成之群的至少1種重複單位(a1),與 選自由下述式(2-a)表示之重複單位及下述式(2-i)表示之重複單位所成之群的至少1種重複單位(a2),且含有全部重複單位之1~20莫耳%的前述重複單位(a1)。A liquid crystal alignment agent for photo-alignment, characterized by containing at least one polymer (A) selected from the group consisting of polyimide precursors and imidized polymers thereof, the polymer (A) having At least one repeating unit (a1) selected from the group consisting of a repeating unit represented by the following formula (1-a) and a repeating unit represented by the following formula (1-i), and At least one repeating unit (a2) selected from the group consisting of the repeating unit represented by the following formula (2-a) and the repeating unit represented by the following formula (2-i), and contains 1 to 20 of all repeating units Molar % of the aforementioned repeating unit (a1).
(式中,X1 表示以下述式(B)表示之4價有機基,X2 表示以下述式(C)表示之4價有機基。R、Z係分別獨立地表示氫原子或碳數1~6之烷基。複數個R及Z,各自可相同亦可相異。Y1 、Y2 係分別獨立地表示以下述式(O)表示之2價有機基)。 (wherein, X 1 represents a tetravalent organic group represented by the following formula (B), and X 2 represents a tetravalent organic group represented by the following formula (C). R and Z each independently represent a hydrogen atom or a carbon number of 1 An alkyl group of ~6. A plurality of R and Z may be the same or different from each other. Y 1 and Y 2 each independently represent a divalent organic group represented by the following formula (O).
(式中,Rb1 ~Rb4 係分別獨立地表示氫原子、鹵素原子,或碳數1~6之烷基。L1 表示單鍵、-CH2 -、-(CH2 )n -(n為2~18之整數),或前述-(CH2 )n -之-CH2 -的至少一部分經 -O-、-C(=O)-或-O-C(=O)-之任一者取代之基。Rc1 ~Rc4 係分別獨立地表示氫原子、鹵素原子、碳數1~6之烷基、碳數2~6之烯基、碳數2~6之炔基、含有氟原子之碳數1~6之1價有機基,或苯基,Rc1 ~Rc4 之至少一者表示上述定義中的氫原子以外之基)。 (In the formula, R b1 to R b4 each independently represent a hydrogen atom, a halogen atom, or an alkyl group having 1 to 6 carbon atoms. L 1 represents a single bond, -CH 2 -, -(CH 2 ) n -(n is an integer from 2 to 18), or at least a part of -CH 2 - of the aforementioned -(CH 2 ) n - is substituted by any one of -O-, -C(=O)- or -OC(=O)- R c1 to R c4 independently represent a hydrogen atom, a halogen atom, an alkyl group with 1 to 6 carbon atoms, an alkenyl group with 2 to 6 carbon atoms, an alkynyl group with 2 to 6 carbon atoms, and a fluorine atom-containing group. A monovalent organic group having 1 to 6 carbon atoms, or a phenyl group, and at least one of R c1 to R c4 represents a group other than a hydrogen atom in the above definition).
(Ar表示苯環、聯苯結構,或萘環,2個Ar可相同亦可相異,環上的任意氫原子亦可經1價有機基取代。Q2 表示 -CH2 -、-(CH2 )n -(n為2~18之整數),或前述-(CH2 )n -之-CH2 -的至少一部分經-O-、-C(=O)-或-O-C(=O)-之任一者取代之基。p為0或1之整數。惟,p為0時,Ar表示聯苯結構,p為1時,2個Ar之至少一者表示萘環。*表示鍵結部位)。 (Ar represents a benzene ring, a biphenyl structure, or a naphthalene ring, the two Ars can be the same or different, and any hydrogen atom on the ring can also be substituted by a monovalent organic group. Q 2 represents -CH 2 -, -(CH 2 ) n - (n is an integer of 2 to 18), or at least a part of -CH 2 - of the aforementioned -(CH 2 ) n - is processed by -O-, -C(=O)- or -OC(=O) A group substituted by any of -. p is an integer of 0 or 1. However, when p is 0, Ar represents a biphenyl structure, and when p is 1, at least one of the two Ars represents a naphthalene ring. * represents a bond part).
再者,本說明書中,*不管任何情況均表示鍵結部位。Boc表示tert-丁氧基羰基。鹵素原子可列舉氟原子、氯原子、溴原子、碘原子。胺基甲酸酯系保護基可列舉tert-丁氧基羰基、9-茀基甲氧基羰基。 [發明之效果]In addition, in this specification, * represents a bond site in any case. Boc represents tert-butoxycarbonyl. The halogen atom includes a fluorine atom, a chlorine atom, a bromine atom, and an iodine atom. Examples of the urethane-based protecting group include tert-butoxycarbonyl and 9-intenylmethoxycarbonyl. [Effect of invention]
本發明之光配向法用液晶配向劑,藉由含有:具有上述重複單位(a1)與上述重複單位(a2),且含有全部重複單位之1~20莫耳%的前述重複單位(a1)之選自由聚醯亞胺前驅物及其醯亞胺化聚合物所成之群的至少1種聚合物(A),發揮可藉由光配向法得到黑顯示時於面內之亮度的偏差被抑制,對比經提高之液晶顯示元件的效果。The liquid crystal aligning agent for a photo-alignment method of the present invention comprises: having the repeating unit (a1) and the repeating unit (a2), and containing 1 to 20 mol% of the repeating unit (a1) of all repeating units. At least one polymer (A) selected from the group consisting of polyimide precursors and imidized polymers thereof, and suppresses variation in in-plane brightness when black display can be obtained by a photo-alignment method , to compare the effect of the improved liquid crystal display element.
說明本發明之光配向法用液晶配向劑(以下亦僅稱為液晶配向劑)。The liquid crystal aligning agent for the photo-alignment method of the present invention (hereinafter also referred to only as a liquid crystal aligning agent) will be described.
<聚合物(A)> 本發明之液晶配向劑,含有選自由聚醯亞胺前驅物及其醯亞胺化聚合物所成之群的至少1種聚合物(A),該聚合物(A)具有:選自由下述式(1-a)表示之重複單位及下述式(1-i)表示之重複單位所成之群的至少1種重複單位(a1),與選自由下述式(2-a)表示之重複單位及下述式(2-i)表示之重複單位所成之群的至少1種重複單位(a2),且含有全部重複單位之1~20莫耳%的前述重複單位(a1)。再者,聚合物(A)可由1種或2種以上構成。<Polymer (A)> The liquid crystal aligning agent of the present invention contains at least one polymer (A) selected from the group consisting of polyimide precursors and imidized polymers thereof, and the polymer (A) has: At least one repeating unit (a1) of the group consisting of the repeating unit represented by the formula (1-a) and the repeating unit represented by the following formula (1-i), and selected from the group consisting of the repeating unit represented by the following formula (2-a) A repeating unit and at least one repeating unit (a2) of the group of repeating units represented by the following formula (2-i), and containing 1 to 20 mol% of the repeating unit (a1) in all repeating units. In addition, the polymer (A) may consist of one type or two or more types.
<重複單位(a1)> 本發明之重複單位(a1),為選自由下述式(1-a)表示之重複單位及下述式(1-i)表示之重複單位所成之群的至少1種重複單位。<Repeat unit (a1)> The repeating unit (a1) of the present invention is at least one repeating unit selected from the group consisting of the repeating unit represented by the following formula (1-a) and the repeating unit represented by the following formula (1-i).
(式中,X1 表示以下述式(B)表示之4價有機基。R、Z係分別獨立地表示氫原子或碳數1~6之烷基。2個R及Z,各自可相同亦可相異。Y1 表示以下述式(O)表示之2價有機基)。 (In the formula, X 1 represents a tetravalent organic group represented by the following formula (B). R and Z each independently represent a hydrogen atom or an alkyl group having 1 to 6 carbon atoms. Two R and Z may be the same as each other. may be different. Y 1 represents a divalent organic group represented by the following formula (O).
(式中,Rb1 ~Rb4 係分別獨立地表示氫原子、鹵素原子,或碳數1~6之烷基。L1 表示單鍵、-CH2 -、-(CH2 )n -(n為2~18之整數),或前述-(CH2 )n -之-CH2 -的至少一部分經 -O-、-C(=O)-或-O-C(=O)-之任一者取代之基)。 (In the formula, R b1 to R b4 each independently represent a hydrogen atom, a halogen atom, or an alkyl group having 1 to 6 carbon atoms. L 1 represents a single bond, -CH 2 -, -(CH 2 ) n -(n is an integer from 2 to 18), or at least a part of -CH 2 - of the aforementioned -(CH 2 ) n - is substituted by any one of -O-, -C(=O)- or -OC(=O)- base).
(Ar表示苯環、聯苯結構,或萘環,2個Ar可相同亦可相異,環上的任意氫原子亦可經1價有機基取代。Q2 表示 -CH2 -、-(CH2 )n -(n為2~18之整數),或前述-(CH2 )n -之-CH2 -的至少一部分經-O-、-C(=O)-或-O-C(=O)-之任一者取代之基。p為0或1之整數。惟,p為0時,Ar表示聯苯結構,p為1時,2個Ar之至少一者表示萘環)。 (Ar represents a benzene ring, a biphenyl structure, or a naphthalene ring, the two Ars can be the same or different, and any hydrogen atom on the ring can also be substituted by a monovalent organic group. Q 2 represents -CH 2 -, -(CH 2 ) n - (n is an integer of 2 to 18), or at least a part of -CH 2 - of the aforementioned -(CH 2 ) n - is processed by -O-, -C(=O)- or -OC(=O) A group substituted by any one of -. p is an integer of 0 or 1. However, when p is 0, Ar represents a biphenyl structure, and when p is 1, at least one of the two Ars represents a naphthalene ring).
前述L1 之較佳例子,就有效率地得到本發明之效果之觀點,為單鍵、-CH2 -或-(CH2 )n -(n為2~18之整數)。 前述Rb1 ~Rb4 之較佳例子,就有效率地得到本發明之效果之觀點,為氫原子。A preferred example of the aforementioned L 1 is a single bond, -CH 2 - or -(CH 2 ) n - (n is an integer of 2 to 18) from the viewpoint of efficiently obtaining the effects of the present invention. Preferred examples of the aforementioned R b1 to R b4 are hydrogen atoms from the viewpoint of efficiently obtaining the effects of the present invention.
前述式(B)表示之4價有機基,就提高液晶配向性之觀點,較佳為下述式(b-1)~(b-2)表示之4價有機基。The tetravalent organic group represented by the aforementioned formula (B) is preferably a tetravalent organic group represented by the following formulae (b-1) to (b-2) from the viewpoint of improving the alignment of liquid crystals.
前述式(O)表示之2價有機基之較佳例子,就有效率地得到本發明之效果之觀點,為下述式(o-1)~(o-7)表示之2價有機基。Preferred examples of the divalent organic group represented by the aforementioned formula (O) are the divalent organic groups represented by the following formulae (o-1) to (o-7) from the viewpoint of efficiently obtaining the effects of the present invention.
<重複單位(a2)> 本發明之重複單位(a2),為選自由下述式(2-a)表示之重複單位及下述式(2-i)表示之重複單位所成之群的至少1種重複單位。<Repeat unit (a2)> The repeating unit (a2) of the present invention is at least one repeating unit selected from the group consisting of the repeating unit represented by the following formula (2-a) and the repeating unit represented by the following formula (2-i).
(式中,X2 表示以下述式(C)表示之4價有機基。R、Z係分別獨立地表示氫原子或碳數1~6之烷基。2個R及Z,各自可相同亦可相異。Y2 係與上述Y1 同義,包含較佳之具體例)。 (wherein, X 2 represents a tetravalent organic group represented by the following formula (C). R and Z each independently represent a hydrogen atom or an alkyl group having 1 to 6 carbon atoms. Two R and Z may be the same as each other. .Y 2 may be different from the above-described system is synonymous with an Y, comprising the specific preferred embodiment).
(式中,Rc1 ~Rc4 係分別獨立地表示氫原子、鹵素原子、碳數1~6之烷基、碳數2~6之烯基、碳數2~6之炔基、含有氟原子之碳數1~6之1價有機基,或苯基,Rc1 ~Rc4 之至少一者表示上述定義中的氫原子以外之基)。 (In the formula, R c1 to R c4 are each independently a hydrogen atom, a halogen atom, an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, an alkynyl group having 2 to 6 carbon atoms, and a fluorine atom-containing group. A monovalent organic group having 1 to 6 carbon atoms, or a phenyl group, and at least one of R c1 to R c4 represents a group other than a hydrogen atom in the above definition).
前述式(C)表示之4價有機基,例如可列舉下述式(Xc-1)~(Xc-6)表示之4價有機基。此等之中,就提高液晶配向性之觀點,尤以(Xc-1)為佳。As a tetravalent organic group represented by the said formula (C), the tetravalent organic group represented by following formula (Xc-1) - (Xc-6) is mentioned, for example. Among them, (Xc-1) is particularly preferable from the viewpoint of improving the alignment of the liquid crystal.
<重複單位(a3)> 前述聚合物(A),亦可為選自由於重複單位(a1)、(a2)以外,具有選自由下述式(3-a)表示之重複單位及下述式(3-i)表示之重複單位所成之群的至少1種重複單位(a3)之聚醯亞胺前驅物及其醯亞胺化聚合物所成之群的至少1種。<Repeat unit (a3)> The aforementioned polymer (A) may be selected from the group consisting of repeating units (a1) and (a2) selected from the group consisting of repeating units represented by the following formula (3-a) and those represented by the following formula (3-i). At least one type of the group consisting of at least one repeating unit of the polyimide precursor of the repeating unit (a3) and at least one type of the group consisting of an imidized polymer thereof.
(式中,X3 表示4價有機基,Y3 表示以下述式(3d)表示之2價有機基。R、Z係與前述式(1-a)同義)。 (In the formula, X 3 represents a tetravalent organic group, and Y 3 represents a divalent organic group represented by the following formula (3d). R and Z are synonymous with the aforementioned formula (1-a).)
(Ar3 表示苯環或聯苯結構,2個Ar3 可相同亦可相異,上述環上之任意氫原子亦可經1價有機基取代。Q3 表示 -(CH2 )n -(n為2~18之整數),或前述-(CH2 )n -之-CH2 -的至少一部分經-O-、-C(=O)-或-O-C(=O)-之任一者取代之基)。 (Ar 3 represents a benzene ring or a biphenyl structure, two Ar 3 may be the same or different, and any hydrogen atom on the above-mentioned ring may also be substituted by a monovalent organic group. Q 3 represents -(CH 2 ) n -(n is an integer from 2 to 18), or at least a part of -CH 2 - of the aforementioned -(CH 2 ) n - is substituted by any one of -O-, -C(=O)- or -OC(=O)- base).
前述式(3d)表示之2價有機基,例如可列舉下述式(3d-1)~(3d-8)表示之2價有機基,但不限定於此。The divalent organic group represented by the aforementioned formula (3d) includes, for example, the divalent organic group represented by the following formulae (3d-1) to (3d-8), but is not limited thereto.
前述聚合物(A),亦可為選自由於重複單位(a1)、(a2)以外,具有選自由下述式(4-a)表示之重複單位及下述式(4-i)表示之重複單位所成之群的至少1種重複單位(a4)之聚醯亞胺前驅物及其醯亞胺化聚合物所成之群的至少1種。The polymer (A) may be selected from the group consisting of repeating units (a1) and (a2) other than repeating units (a1) and (a2), and may have repeating units selected from the following formula (4-a) and the following formula (4-i) At least one type of the group consisting of at least one repeating unit of the repeating unit (a4) and at least one type of the group consisting of the polyimide precursor and its imidized polymer.
(式中,R、Z係與前述式(1-a)同義。X4 表示4價有機基,Y4 表示分子內具有基「-N(D)-(D表示胺基甲酸酯系保護基)」之碳數6~30之2價有機基)。 (In the formula, R and Z are synonymous with the aforementioned formula (1-a). X 4 represents a tetravalent organic group, Y 4 represents a group having in the molecule "-N(D)-(D represents a urethane-based protection Divalent organic group with 6 to 30 carbon atoms).
Y4 中之分子內具有基「-N(D)-(D表示胺基甲酸酯系保護基)」之碳數6~30之2價有機基之具體例子,可列舉具有下述式(4-1)表示之部分結構的2價有機基,或下述式(4-2)表示之2價有機基。A specific example of a divalent organic group having 6 to 30 carbon atoms having a group "-N(D)-(D represents a urethane-based protecting group)" in the molecule of Y 4 includes the following formula ( A divalent organic group of a partial structure represented by 4-1), or a divalent organic group represented by the following formula (4-2).
式中,Q5 為單鍵、-(CH2 )n -(n為1~20之整數),或-(CH2 )n -的任意之-CH2 -經-O-、-COO-、-OCO-、 -NQ9 -、-NQ9 -CO-、-CO-NQ9 -、-NQ9 -CO-NQ10 -、-NQ9 -COO-或-O-COO-取代之基,Q9 及Q10 係分別獨立地表示氫原子或1價有機基;Q6 、Q7 係分別獨立地表示-H、具有 -NHD之基,或具有-N(D)2 之基。Q8 表示具有-NHD之基,或具有-N(D)2 之基。D表示胺基甲酸酯系保護基。惟,Q5 、Q6 及Q7 之至少一者,於基中具有胺基甲酸酯系保護基。Q9 及Q10 中之1價有機基之具體例子,可列舉碳數1~6之烷基、碳數2~6之烯基、碳數2~6之炔基、含有氟原子之碳數1~6之烷基、前述胺基甲酸酯系保護基、碳數1~6之烷氧基烷基。In the formula, Q 5 is a single bond, -(CH 2 ) n - (n is an integer from 1 to 20), or any -CH 2 - of -(CH 2 ) n - through -O-, -COO-, -OCO-, -NQ 9 -, - NQ 9 -CO -, - CO-NQ 9 -, - NQ 9 -CO-NQ 10 -, - NQ 9 -COO- or -O-COO- group of substituents, Q 9 and Q 10 each independently represent a hydrogen atom or a monovalent organic group; Q 6 and Q 7 each independently represent -H, a group having -NHD, or a group having -N(D) 2 . Q 8 represents a group having -NHD, or a group having -N(D) 2 . D represents a urethane-based protecting group. However, at least one of Q 5 , Q 6 and Q 7 has a urethane-based protecting group in the group. Specific examples of the monovalent organic group in Q 9 and Q 10 include alkyl groups with 1 to 6 carbon atoms, alkenyl groups with 2 to 6 carbon atoms, alkynyl groups with 2 to 6 carbon atoms, and carbon atoms with fluorine atoms. An alkyl group of 1 to 6, the aforementioned urethane-based protecting group, and an alkoxyalkyl group of 1 to 6 carbon atoms.
此處,Y4 例如可列舉下述式(Y4-1)~(Y4-4)表示之結構,但不限定於此。Here, Y 4, for example, ~ (Y4-4) of the above compound represented by formula (Y4-1) structure, but is not limited thereto.
前述聚合物(A),亦可為選自由於重複單位(a1)及(a2)之外,具有選自由下述式(5-a)表示之重複單位及下述式(5-i)表示之重複單位所成之群的至少1種重複單位(a5)之聚醯亞胺前驅物及其醯亞胺化聚合物所成之群的至少1種。The polymer (A) may be selected from the group consisting of repeating units (a1) and (a2), and may have repeating units selected from the following formula (5-a) and the following formula (5-i) At least one of the group consisting of at least one repeating unit of the repeating unit (a5) and the group consisting of the polyimide precursor and its imidized polymer.
式(5-a)及式(5-i)中,R、Z係與前述式(1-a)同義。X5 表示4價有機基,Y5 表示2價有機基。惟,Y5 表示前述式(3d)表示之2價有機基,或分子內具有基「-N(D)-(D表示胺基甲酸酯系保護基)」的碳數6~30之2價有機基以外之結構,X5 與前述式(B)表示之4價有機基或前述式(C)表示之4價有機基同義時,Y5 表示以前述式(O)表示之2價有機基以外之結構。 In formula (5-a) and formula (5-i), R and Z are synonymous with the aforementioned formula (1-a). X 5 represents a tetravalent organic group, and Y 5 represents a divalent organic group. However, Y 5 represents a divalent organic group represented by the aforementioned formula (3d), or 2 of 6 to 30 carbon atoms having a group "-N(D)-(D represents a urethane-based protecting group)" in the molecule A structure other than a valent organic group, when X 5 is synonymous with a tetravalent organic group represented by the aforementioned formula (B) or a tetravalent organic group represented by the aforementioned formula (C), Y 5 represents a bivalent organic group represented by the aforementioned formula (O) structure other than the base.
式(5-a)及式(5-i)中,Y5 之具體例子,可列舉由p-苯二胺、2,3,5,6-四甲基-p-苯二胺、2,5-二甲基-p-苯二胺、m-苯二胺、2,4-二甲基-m-苯二胺、2,5-二胺基甲苯、2,6-二胺基甲苯、4,4’-二胺基聯苯、3,3’-二甲基-4,4’-二胺基聯苯、3,3’-二甲氧基-4,4’-二胺基聯苯、3,3’-二氟-4,4’-二胺基聯苯、3,3’-雙(三氟甲基)-4,4’-二胺基聯苯、3,4’-二胺基聯苯、3,3’-二胺基聯苯、2,2’-二胺基聯苯、2,3’-二胺基聯苯、4,4’-二胺基二苯基甲烷、3,3’-二胺基二苯基甲烷、3,4’-二胺基二苯基甲烷、4,4’-二胺基二苯基醚、3,3’-二胺基二苯基醚、3,4’-二胺基二苯基醚、4,4’-二胺基二苯甲酮、4,4’-二胺基苯甲醯苯胺、4,4’-二胺基偶氮苯、1,5-二胺基萘、1,6-二胺基萘、1,7-二胺基萘、2,5-二胺基萘、2,6-二胺基萘、2,7-二胺基萘、1,4-雙(4-胺基苯氧基)苯、1,3-雙(4-胺基苯氧基)苯、1,4-雙(4-胺基苯基)苯、1,3-雙(4-胺基苯基)苯、1,4-雙(4-胺基苄基)苯等之芳香族二胺去除2個胺基而得的2價有機基,此外可列舉後述Y6 所例示之2價有機基。In formula (5-a) and formula (5-i), specific examples of Y 5 include p-phenylenediamine, 2,3,5,6-tetramethyl-p-phenylenediamine, 2, 5-dimethyl-p-phenylenediamine, m-phenylenediamine, 2,4-dimethyl-m-phenylenediamine, 2,5-diaminotoluene, 2,6-diaminotoluene, 4,4'-diaminobiphenyl, 3,3'-dimethyl-4,4'-diaminobiphenyl, 3,3'-dimethoxy-4,4'-diaminobiphenyl Benzene, 3,3'-difluoro-4,4'-diaminobiphenyl, 3,3'-bis(trifluoromethyl)-4,4'-diaminobiphenyl, 3,4'- Diaminobiphenyl, 3,3'-diaminobiphenyl, 2,2'-diaminobiphenyl, 2,3'-diaminobiphenyl, 4,4'-diaminodiphenyl Methane, 3,3'-diaminodiphenylmethane, 3,4'-diaminodiphenylmethane, 4,4'-diaminodiphenyl ether, 3,3'-diaminodiphenyl Phenyl ether, 3,4'-diaminodiphenyl ether, 4,4'-diaminobenzophenone, 4,4'-diaminobenzylaniline, 4,4'-diamine azobenzene, 1,5-diaminonaphthalene, 1,6-diaminonaphthalene, 1,7-diaminonaphthalene, 2,5-diaminonaphthalene, 2,6-diaminonaphthalene, 2,7-Diaminonaphthalene, 1,4-bis(4-aminophenoxy)benzene, 1,3-bis(4-aminophenoxy)benzene, 1,4-bis(4-amine 2 obtained by removing two amine groups from aromatic diamines such as 1,3-bis(4-aminophenyl)benzene, 1,4-bis(4-aminobenzyl)benzene, etc. As the valent organic group, the divalent organic group exemplified by Y 6 described later can also be mentioned.
前述X3 、X4 及X5 之4價有機基之結構並無特殊限定,可分別獨立地選擇任意之結構。較佳的具體例子可列舉下述式(X1-1)~(X1-44)。The structure of the tetravalent organic group of the aforementioned X 3 , X 4 and X 5 is not particularly limited, and an arbitrary structure can be independently selected. Preferred specific examples include the following formulae (X1-1) to (X1-44).
式(X1-1)~(X1-4)中,R3 ~R23 係分別獨立地為氫原子、鹵素原子、碳數1~6之烷基、碳數2~6之烯基、碳數2~6之炔基、含有氟原子之碳數1~6之1價有機基,或苯基。就液晶配向性之觀點,R3 ~R23 較佳為氫原子、鹵素原子、甲基,或乙基;更佳為氫原子,或甲基。 In formulas (X1-1) to (X1-4), R 3 to R 23 are independently a hydrogen atom, a halogen atom, an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, and a carbon number. An alkynyl group of 2 to 6, a monovalent organic group of 1 to 6 carbon atoms containing a fluorine atom, or a phenyl group. From the viewpoint of liquid crystal alignment, R 3 to R 23 are preferably a hydrogen atom, a halogen atom, a methyl group, or an ethyl group; more preferably a hydrogen atom or a methyl group.
式(X1-1)之具體例子,可列舉下述式(X1-1-1)~(X1-1-6)。就液晶配向性及光反應之感度的觀點,更佳為(X1-1-1)~(X1-1-2)、特佳為(X1-1-2)。Specific examples of the formula (X1-1) include the following formulae (X1-1-1) to (X1-1-6). From the viewpoint of the liquid crystal alignment and the sensitivity of the photoreaction, (X1-1-1) to (X1-1-2) are more preferable, and (X1-1-2) is particularly preferable.
就良好地得到本發明之效果的觀點,聚合物(A),較佳含有全部重複單位之1~20莫耳%的重複單位(a1)、更佳含有1~15莫耳%。From the viewpoint of obtaining the effects of the present invention favorably, the polymer (A) preferably contains 1 to 20 mol % of the repeating unit (a1), more preferably 1 to 15 mol % of the total repeating unit.
就良好地得到本發明之效果的觀點,聚合物(A),較佳重複單位(a1)及重複單位(a2)之合計為全部重複單位之5莫耳%以上、更佳為10莫耳%以上。From the viewpoint of obtaining the effect of the present invention favorably, the polymer (A), preferably the total of the repeating unit (a1) and the repeating unit (a2) is 5 mol% or more of all repeating units, more preferably 10 mol% above.
就良好地得到本發明之效果的觀點,聚合物(A),較佳含有全部重複單位之1~95莫耳%的重複單位(a3)、更佳含有1~90莫耳%、又更佳含有5~90莫耳%。此時,重複單位(a1)及重複單位(a2)之合計,較佳為99莫耳%以下、更佳為95莫耳%以下。From the viewpoint of obtaining the effects of the present invention well, the polymer (A) preferably contains 1 to 95 mol% of the repeating units (a3) of all repeating units, more preferably 1 to 90 mol%, and more preferably Contains 5~90 mol%. In this case, the total of the repeating unit (a1) and the repeating unit (a2) is preferably 99 mol % or less, more preferably 95 mol % or less.
就良好地得到本發明之效果的觀點,聚合物(A),較佳含有全部重複單位之1~40莫耳%的重複單位(a4)、更佳含有1~30莫耳%、又更佳含有1~25莫耳%。From the viewpoint of obtaining the effect of the present invention favorably, the polymer (A) preferably contains 1 to 40 mol% of the repeating unit (a4) of all repeating units, more preferably 1 to 30 mol%, and more preferably Contains 1~25 mol%.
<聚合物(B)> 本發明之液晶配向劑,就使源自殘留DC之殘像少的觀點,亦可含有具有下述式(6)表示之重複單位的聚合物(B)。再者,聚合物(B),不於同一分子內具有上述重複單位(a1)與重複單位(a2)。又,聚合物(B)可由1種或2種以上構成,構成聚合物(B)之重複單位可由1種或2種以上構成。<Polymer (B)> The liquid crystal aligning agent of this invention may contain the polymer (B) which has a repeating unit represented by following formula (6) from a viewpoint of reducing the residual image derived from residual DC. In addition, the polymer (B) does not have the above-mentioned repeating unit (a1) and repeating unit (a2) in the same molecule. In addition, the polymer (B) may be composed of one kind or two or more kinds, and the repeating unit constituting the polymer (B) may be composed of one kind or two or more kinds.
(X6 為4價有機基,Y6 為2價有機基。R、Z係與式(1-a)同義)。 (X 6 is a tetravalent organic group, and Y 6 is a divalent organic group. R and Z are synonymous with formula (1-a)).
前述式X6 中之4價有機基,可列舉源自非環式脂肪族四羧酸二酐之4價有機基、源自脂環式四羧酸二酐之4價有機基、源自芳香族四羧酸二酐之4價有機基等。源自非環式脂肪族四羧酸二酐之4價有機基,及源自脂環式四羧酸二酐之4價有機基之具體例子,可列舉由下述式(x-1)~(x-13)中選出的結構。In the foregoing formula X 64 monovalent organic group, derived from a tetravalent organic group include dianhydrides of a non-cyclic aliphatic tetracarboxylic acid, derived from a tetravalent organic group of the alicyclic tetracarboxylic acid dianhydride, derived from an aromatic The tetravalent organic group of tetracarboxylic dianhydride, etc. Specific examples of the tetravalent organic group derived from acyclic aliphatic tetracarboxylic dianhydride and the tetravalent organic group derived from alicyclic tetracarboxylic dianhydride include the following formulas (x-1) to Structure selected in (x-13).
(上述式(x-1)~(x-13)中,R1 ~R4 係分別獨立地表示氫原子、鹵素原子、碳數1~6之烷基、碳數2~6之烯基、碳數2~6之炔基、具有氟原子之碳數1~6之1價有機基或苯基。R5 及R6 係分別獨立地表示氫原子或甲基)。 (In the above formulae (x-1) to (x-13), R 1 to R 4 independently represent a hydrogen atom, a halogen atom, an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, An alkynyl group having 2 to 6 carbon atoms, a monovalent organic group having a fluorine atom having 1 to 6 carbon atoms, or a phenyl group. R 5 and R 6 each independently represent a hydrogen atom or a methyl group).
其中,上述式(x-1),尤以選自由下述式(x1-1)~(x1-6)所成之群者為佳。Among them, the above formula (x-1) is preferably selected from the group formed by the following formulae (x1-1) to (x1-6).
上述式(x1-1)~(x1-6)中,*1表示鍵結於一方之酸酐基的鍵結部位,又,*2表示鍵結於另一方之酸酐基的鍵結部位。 In the above-mentioned formulae (x1-1) to (x1-6), *1 represents a bond site to one acid anhydride group, and *2 represents a bond site to the other acid anhydride group.
芳香族四羧酸二酐,係指藉由鍵結於苯環、萘環等之芳香環的羧基進行分子內脫水所得之酸二酐。列舉具體例時,可列舉前述式(X1-28)~(X1-40)表示之4價有機基。The aromatic tetracarboxylic dianhydride refers to an acid dianhydride obtained by intramolecular dehydration of a carboxyl group bonded to an aromatic ring such as a benzene ring and a naphthalene ring. When a specific example is given, the tetravalent organic group represented by the said formula (X1-28) - (X1-40) is mentioned.
前述式Y6 中之2價有機基,可列舉由含氮原子之雜環、具有選自由二級胺基及三級胺基所成之群的至少一種含氮原子之結構(以下亦稱為含氮原子之結構)之二胺、2,4-二胺基酚、3,5-二胺基酚、3,5-二胺基苯甲醇、2,4-二胺基苯甲醇、4,6-二胺基間苯二酚、2,4-二胺基苯甲酸、2,5-二胺基苯甲酸、3,5-二胺基苯甲酸、下述式(3b-1)~式(3b-4)表示之二胺化合物等之具有羧基之二胺、4-(2-(甲基胺基)乙基)苯胺、4-(2-胺基乙基)苯胺、4,4’-二胺基二苯基甲烷、4,4’-二胺基二苯甲酮、4,4’-二胺基二苯基醚、4,4’-二胺基苯甲醯苯胺、4,4’-二胺基偶氮苯、1-(4-胺基苯基)-1,3,3-三甲基-1H-茚烷-5-胺、1-(4-胺基苯基)-2,3-二氫-1,3,3-三甲基-1H-茚-6-胺、1,3-雙(4-胺基苯乙基)脲等之具有脲鍵之二胺、甲基丙烯酸2-(2,4-二胺基苯氧基)乙酯、2,4-二胺基-N,N-二烯丙基苯胺等之末端具有光聚合性基之二胺、膽甾烷氧基-3,5-二胺基苯、膽甾烯氧基-3,5-二胺基苯、膽甾烷氧基-2,4-二胺基苯、3,5-二胺基苯甲酸膽甾烷基酯、3,5-二胺基苯甲酸膽甾烯基酯、3,5-二胺基苯甲酸羊毛甾烷基酯、3,6-雙(4-胺基苄醯氧基)膽甾烷等之具有類固醇骨架之二胺、下述式(V-1)~(V-8)表示之二胺、1,3-雙(3-胺基丙基)-四甲基二矽氧烷等之具有矽氧烷鍵之二胺、下述式(Ox-1)~(Ox-2)等之具有噁唑啉結構之二胺等之二胺去除2個胺基而得的2價有機基、國際公開第2018/117239號記載之式(Y-1)~(Y-167)之任一者表示之基等。The divalent organic group in the aforementioned formula Y 6 includes a nitrogen atom-containing heterocycle, a structure having at least one nitrogen-containing atom selected from the group consisting of a secondary amine group and a tertiary amine group (hereinafter also referred to as Nitrogen-containing structure) diamine, 2,4-diaminophenol, 3,5-diaminophenol, 3,5-diaminobenzyl alcohol, 2,4-diaminobenzyl alcohol, 4, 6-Diaminoresorcinol, 2,4-diaminobenzoic acid, 2,5-diaminobenzoic acid, 3,5-diaminobenzoic acid, the following formulas (3b-1) to formula Diamines having carboxyl groups such as diamine compounds represented by (3b-4), 4-(2-(methylamino)ethyl)aniline, 4-(2-aminoethyl)aniline, 4,4' -Diaminodiphenylmethane, 4,4'-diaminobenzophenone, 4,4'-diaminodiphenyl ether, 4,4'-diaminobenzylaniline, 4, 4'-Diaminoazobenzene, 1-(4-aminophenyl)-1,3,3-trimethyl-1H-indan-5-amine, 1-(4-aminophenyl) -2,3-dihydro-1,3,3-trimethyl-1H-indene-6-amine, 1,3-bis(4-aminophenethyl)urea and other diamines having urea bonds, 2-(2,4-Diaminophenoxy)ethyl methacrylate, 2,4-diamino-N,N-diallylaniline, etc. Diamines having photopolymerizable groups at the terminals, choles Stalkoxy-3,5-diaminobenzene, Cholestyloxy-3,5-diaminobenzene, Cholestyloxy-2,4-diaminobenzene, 3,5-diamine Cholestyl benzoate, Cholestyl 3,5-diaminobenzoate, Lanostanyl 3,5-diaminobenzoate, 3,6-bis(4-aminobenzyl) Diamines having steroid skeletons such as acyloxy)cholestane, diamines represented by the following formulae (V-1) to (V-8), 1,3-bis(3-aminopropyl)-tetrakis Diamines with siloxane bonds such as methyldisiloxane, diamines with oxazoline structures such as the following formulas (Ox-1)~(Ox-2), etc. are removed 2 amine groups The obtained divalent organic group, a group represented by any one of the formulae (Y-1) to (Y-167) described in International Publication No. 2018/117239, and the like.
(式(3b-1)中,A1 表示單鍵、-CH2 -、-C2 H4 -、-C(CH3 )2 -、-CF2 -、-C(CF3 )2 -、-O-、-CO-、-NH-、-N(CH3 )-、 -CONH-、-NHCO-、-CH2 O-、-OCH2 -、-COO-、-OCO-、 -CON(CH3 )-或N(CH3 )CO-,m1及m2係分別獨立地表示0~4之整數,且m1+m2表示1~4之整數。式(3b-2)中,m3及m4係分別獨立地表示1~5之整數。式(3b-3)中,A2 表示碳數1~5之直鏈或分支烷基,m5表示1~5之整數。式(3b-4)中,A3 及A4 係分別獨立地表示單鍵、-CH2 -、-C2 H4 -、-C(CH3 )2 -、-CF2 -、-C(CF3 )2 -、-O-、-CO-、-NH-、-N(CH3 )-、 -CONH-、-NHCO-、-CH2 O-、-OCH2 -、-COO-、-OCO-、 -CON(CH3 )-或-N(CH3 )CO-,m6表示1~4之整數)。 (In formula (3b-1), A 1 represents a single bond, -CH 2 -, -C 2 H 4 -, -C(CH 3 ) 2 -, -CF 2 -, -C(CF 3 ) 2 -, -O -, - CO -, - NH -, - N (CH 3) -, -CONH -, - NHCO -, - CH 2 O -, - OCH 2 -, - COO -, - OCO-, -CON ( CH 3 )- or N(CH 3 )CO-, m1 and m2 each independently represent an integer from 0 to 4, and m1+m2 represent an integer from 1 to 4. In formula (3b-2), m3 and m4 are Each independently represents an integer of 1 to 5. In formula (3b-3), A 2 represents a straight-chain or branched alkyl group having 1 to 5 carbon atoms, and m5 represents an integer of 1 to 5. In formula (3b-4), A 3 and A 4 each independently represent a single bond, -CH 2 -, -C 2 H 4 -, -C(CH 3 ) 2 -, -CF 2 -, -C(CF 3 ) 2 -, -O -, -CO-, -NH-, -N(CH 3 )-, -CONH-, -NHCO-, -CH 2 O-, -OCH 2 -, -COO-, -OCO-, -CON(CH 3 )- or -N(CH 3 )CO-, m6 represents an integer from 1 to 4).
(Xv1 ~Xv4 、Xp1 ~Xp2 係分別獨立地表示-(CH2 )a -(a為1~15之整數)、-CONH-、-NHCO-、-CON(CH3 )-、-NH-、 -O-、-CH2 O-、-CH2 OCO-、-COO-,或-OCO-,Xv5 表示 -O-、-CH2 O-、-CH2 OCO-、-COO-,或-OCO-。Xa 表示單鍵、-O-、-NH-、-O-(CH2 )m -O-(m表示1~6之整數),Rv1 ~Rv4 、R1a ~R1b 係分別獨立地表示碳數1~20之烷基、碳數1~20之烷氧基或碳數2~20之烷氧基烷基。XV7 ~XV8 係分別獨立地表示-O-、-CH2 O-、-COO-或-OCO-)。 (X v1 to X v4 and X p1 to X p2 independently represent -(CH 2 ) a - (a is an integer of 1 to 15), -CONH-, -NHCO-, -CON(CH 3 )-, -NH-, -O-, -CH 2 O-, -CH 2 OCO-, -COO-, or -OCO-, X v5 means -O-, -CH 2 O-, -CH 2 OCO-, -COO -, or -OCO-. X a represents a single bond, -O-, -NH-, -O-(CH 2 ) m -O- (m represents an integer from 1 to 6), R v1 ~R v4 , R 1a ~R 1b represent independently an alkyl group having 1 to 20 carbon atoms, an alkoxy group having a carbon number of 1 to 20, or an alkoxyalkyl group having a carbon number of 2 to 20. X V7 to X V8 each independently represent - O -, - CH 2 O - , - COO- or -OCO-).
上述含氮原子之雜環,例如可列舉吡咯、咪唑、吡唑、三唑、吡啶、嘧啶、嗒嗪、吡嗪、吲哚、苯并咪唑、嘌呤、喹啉、異喹啉、啶、喹噁啉、酞嗪、三嗪、咔唑、吖啶、哌啶、哌嗪、吡咯啶、六亞甲亞胺等。其中尤以吡啶、嘧啶、吡嗪、哌啶、哌嗪、喹啉、咔唑或吖啶為佳。Examples of the nitrogen-containing heterocyclic ring include pyrrole, imidazole, pyrazole, triazole, pyridine, pyrimidine, pyrazine, pyrazine, indole, benzimidazole, purine, quinoline, isoquinoline, pyridine, quinoxaline, phthalazine, triazine, carbazole, acridine, piperidine, piperazine, pyrrolidine, hexamethyleneimine, etc. Among them, pyridine, pyrimidine, pyrazine, piperidine, piperazine, quinoline, carbazole or acridine are particularly preferred.
具有含氮原子之結構之二胺可具有的二級胺基及三級胺基,例如係以下述式(n)表示。The secondary amine group and the tertiary amine group which the diamine having a nitrogen atom-containing structure may have are represented by, for example, the following formula (n).
上述式(n)中,R表示氫原子或碳數1~10之1價烴基。「*1」表示鍵結於烴基之鍵結部位。 In the above formula (n), R represents a hydrogen atom or a monovalent hydrocarbon group having 1 to 10 carbon atoms. "*1" represents the bonding site to which the hydrocarbon group is bonded.
上述式R之1價烴基,例如可列舉甲基、乙基、丙基等之烷基;環己基等之環烷基;苯基、甲基苯基等之芳基等。R較佳為氫原子或甲基。Examples of the monovalent hydrocarbon group of the above formula R include alkyl groups such as methyl, ethyl, and propyl; cycloalkyl groups such as cyclohexyl; and aryl groups such as phenyl and methylphenyl. R is preferably a hydrogen atom or a methyl group.
具有含氮原子之結構之二胺之具體例子,例如可列舉2,6-二胺基吡啶、3,4-二胺基吡啶、2,4-二胺基嘧啶、3,6-二胺基咔唑、N-甲基-3,6-二胺基咔唑、1,4-雙-(4-胺基苯基)哌嗪、3,6-二胺基吖啶、N-乙基-3,6-二胺基咔唑、N-苯基-3,6-二胺基咔唑、N,N’-雙(4-胺基苯基)聯苯胺、N,N’-雙(4-胺基苯基)-N,N’-二甲基聯苯胺、4,4’-二胺基二苯胺、N,N-雙(4-胺基苯基)-甲胺、下述式(z-1)~式(z-23)表示之化合物。Specific examples of the diamine having a nitrogen atom-containing structure include 2,6-diaminopyridine, 3,4-diaminopyridine, 2,4-diaminopyrimidine, and 3,6-diaminopyridine Carbazole, N-methyl-3,6-diaminocarbazole, 1,4-bis-(4-aminophenyl)piperazine, 3,6-diaminoacridine, N-ethyl- 3,6-Diaminocarbazole, N-phenyl-3,6-diaminocarbazole, N,N'-bis(4-aminophenyl)benzidine, N,N'-bis(4 -aminophenyl)-N,N'-dimethylbenzidine, 4,4'-diaminodiphenylamine, N,N-bis(4-aminophenyl)-methylamine, the following formula ( z-1) to compounds represented by formula (z-23).
就源自殘留DC之殘像少的觀點,聚合物(B),較佳為包含重複單位的聚合物,該重複單位中,Y6 為選自由:由具有含氮原子之結構的二胺、2,4-二胺基酚、3,5-二胺基酚、3,5-二胺基苯甲醇、2,4-二胺基苯甲醇、4,6-二胺基間苯二酚、上述具有羧基之二胺或前述具有脲鍵之二胺去除2個胺基而得之2價有機基所成之群的2價有機基(此等亦總稱為特定之2價有機基)。The polymer (B) is preferably a polymer comprising a repeating unit from the viewpoint of less residual image due to residual DC, and in the repeating unit, Y 6 is selected from the group consisting of diamines having a nitrogen atom-containing structure, 2,4-diaminophenol, 3,5-diaminophenol, 3,5-diaminobenzyl alcohol, 2,4-diaminobenzyl alcohol, 4,6-diaminoresorcinol, The above-mentioned diamine having a carboxyl group or the above-mentioned diamine having a urea bond is a group of divalent organic groups obtained by removing two amine groups (these are also collectively referred to as specific divalent organic groups).
聚合物(B),就源自殘留DC之殘像少的觀點,可含有聚合物(B)中所含的全部重複單位之1莫耳%以上的Y6 為前述特定之2價有機基的重複單位、亦可含有5莫耳%以上。The polymer (B) may contain 1 mol % or more of the total repeating units contained in the polymer (B) from the viewpoint of less residual image due to residual DC. Y 6 is the above-mentioned specific divalent organic group. Repeating units may also contain more than 5 mol%.
就源自殘留DC之殘像少的觀點,聚合物(A)與聚合物(B)之含有比例,以[聚合物(A)]/[聚合物(B)]之質量比計,可為10/90~90/10、可為20/80~90/10、亦可為20/80~80/20。From the viewpoint of less afterimages due to residual DC, the content ratio of the polymer (A) and the polymer (B) in terms of the mass ratio of [polymer (A)]/[polymer (B)] may be 10/90~90/10, can be 20/80~90/10, can also be 20/80~80/20.
<聚醯胺酸、聚醯胺酸酯及聚醯亞胺之製造方法> 本發明所用的聚醯亞胺前驅物之聚醯胺酸酯、聚醯胺酸及聚醯亞胺,例如,可藉由如國際公開第2013/157586號記載之公知方法合成。 具體而言,係藉由使二胺成分與四羧酸衍生物成分,在溶劑中進行(縮聚合)反應來合成。上述四羧酸衍生物成分,可列舉四羧酸二酐或其衍生物(四羧酸二鹵化物、四羧酸二酯,或四羧酸二酯二鹵化物)。聚合物(A)或(B)之一部分包含醯胺酸結構時,例如可藉由使四羧酸二酐成分與二胺成分進行反應,得到具有醯胺酸結構之聚合物(聚醯胺酸)。作為溶劑,只要係會溶解所生成之聚合物者,則無特殊限定。<The manufacturing method of polyamide acid, polyamide ester and polyimide> The polyimide precursor used in the present invention, the polyamide ester, the polyamide acid, and the polyimide, can be synthesized, for example, by a known method as described in International Publication No. 2013/157586. Specifically, it is synthesized by subjecting a diamine component and a tetracarboxylic acid derivative component to (polycondensation) reaction in a solvent. As said tetracarboxylic-acid derivative component, tetracarboxylic dianhydride or its derivative(s) (tetracarboxylic-acid dihalide, tetracarboxylic-acid diester, or tetracarboxylic-acid diester dihalide) is mentioned. When a part of the polymer (A) or (B) contains an aramidic acid structure, for example, by reacting a tetracarboxylic dianhydride component with a diamine component, a polymer having an aramidic acid structure (polyacidic acid) can be obtained. ). The solvent is not particularly limited as long as it dissolves the produced polymer.
用以得到聚合物(A)之聚醯亞胺前驅物的二胺成分及四羧酸衍生物成分,係分別依聚合物(A)所具有的上述式(1-a)、式(2-a),及依需要含有之式(3-a)、式(4-a)、式(5-a)表示之重複單位,以得到該重複單位之結構的方式選擇來使用。 例如,具有聚合物(A)所具有的式(1-a)表示之重複單位時,二胺成分,係使用具有-N(Z)-Y1 -N(Z)-之結構(Y1 、Z之定義係與上述相同)的二胺,又,四羧酸衍生物成分,係使用具有下述式之結構的四羧酸衍生物。The diamine component and the tetracarboxylic acid derivative component used to obtain the polyimide precursor of the polymer (A) are based on the above-mentioned formula (1-a) and formula (2-) of the polymer (A), respectively. a), and the repeating units represented by formula (3-a), formula (4-a), and formula (5-a) according to need, are selected and used in a way to obtain the structure of the repeating unit. For example, a polymer (A) has the formula (1-a) represents a repeating unit of the diamine component, based having -N (Z) -Y 1 -N ( Z) - The structure of (Y 1, The definition of Z is the same as the above-mentioned diamine, and as the tetracarboxylic acid derivative component, a tetracarboxylic acid derivative having a structure of the following formula is used.
(X1 之定義係與上述相同)。 ( The definition of X 1 is the same as above).
聚醯胺酸酯,例如,可藉由[I]使上述方法所得之聚醯胺酸與酯化劑反應之方法、[II]使四羧酸二酯與二胺反應之方法、[III]使四羧酸二酯二鹵化物與二胺反應之方法等之已知方法得到。The polyamic acid ester can be, for example, [I] a method of reacting the polyamic acid obtained by the above method with an esterifying agent, [II] a method of reacting a tetracarboxylic acid diester with a diamine, [III] It can be obtained by a known method such as a method of reacting a tetracarboxylic acid diester dihalide with a diamine.
得到聚醯亞胺之方法,可列舉將含有上述反應所得之聚醯胺酸、聚醯胺酸酯等之聚醯亞胺前驅物的溶液直接加熱之熱醯亞胺化,或對上述溶液添加觸媒之觸媒醯亞胺化。 本發明所用的聚醯亞胺中,醯胺酸基之閉環率(亦稱為醯亞胺化率)不一定必需為100%,可依用途或目的任意調整。 例如,聚醯亞胺之醯亞胺化率,就提高聚醯亞胺塗料之溶解性的觀點,可為20~100%、50~99%,或70~99%。The method for obtaining polyimide includes thermal imidization by directly heating a solution containing a polyimide precursor such as polyimide and polyimide obtained by the above-mentioned reaction, or adding to the above-mentioned solution. Catalyst catalyzed imidization. In the polyimide used in the present invention, the ring closure ratio of the amide acid group (also referred to as the amide imidization ratio) does not necessarily have to be 100%, and can be adjusted arbitrarily according to the application or purpose. For example, the imidization rate of the polyimide can be 20-100%, 50-99%, or 70-99% from the viewpoint of improving the solubility of the polyimide coating.
<聚合物之溶液黏度/分子量> 本發明所用的聚醯胺酸、聚醯胺酸酯及聚醯亞胺,當以其為濃度10~15質量%之溶液時,就作業性之觀點,較佳為例如具有10~1000mPa・s之溶液黏度者,但不特別限定。再者,上述聚合物之溶液黏度(mPa・s),係對於使用該聚合物之良溶劑(例如γ-丁內酯、N-甲基-2-吡咯啶酮等)所調製的濃度10~15質量%之聚合物溶液,使用E型旋轉黏度計於25℃測定的值。<Solution viscosity/molecular weight of polymer> When the polyamic acid, polyamic acid ester and polyimide used in the present invention are a solution having a concentration of 10 to 15 mass %, it is preferable to have, for example, 10 to 1000 mPa・s from the viewpoint of workability. The viscosity of the solution is not particularly limited. In addition, the solution viscosity (mPa・s) of the above-mentioned polymer is a concentration of 10~ 15 mass % polymer solution, the value measured at 25 degreeC using the E-type rotational viscometer.
上述聚醯胺酸、聚醯胺酸酯及聚醯亞胺之藉由凝膠滲透層析(GPC)所測定之聚苯乙烯換算的重量平均分子量(Mw),較佳為1,000~500,000、更佳為2,000~ 300,000。又,以Mw與藉由GPC所測定之聚苯乙烯換算的數平均分子量(Mn)之比所表示之分子量分布(Mw/Mn),較佳為15以下、更佳為10以下。藉由為如此的分子量範圍,可確保液晶顯示元件之良好的配向性及安定性。The weight-average molecular weight (Mw) in terms of polystyrene measured by gel permeation chromatography (GPC) of the above-mentioned polyamic acid, polyamic acid ester and polyimide is preferably 1,000 to 500,000, or more Preferably 2,000~300,000. Moreover, the molecular weight distribution (Mw/Mn) represented by the ratio of Mw to the polystyrene conversion number average molecular weight (Mn) measured by GPC is preferably 15 or less, more preferably 10 or less. By being in such a molecular weight range, favorable alignment and stability of the liquid crystal display element can be ensured.
<液晶配向劑> 本發明之液晶配向劑,含有聚合物(A)及依需要之聚合物(B)。本發明之液晶配向劑,於聚合物(A)、聚合物(B)以外,亦可含有其他聚合物。其他聚合物之種類,可列舉聚酯、聚醯胺、聚脲、聚有機矽氧烷、纖維素衍生物、聚縮醛、聚苯乙烯或其衍生物、聚(苯乙烯-苯基馬來醯亞胺)衍生物、聚(甲基)丙烯酸酯等。<Liquid crystal alignment agent> The liquid crystal aligning agent of the present invention contains a polymer (A) and a polymer (B) as required. In addition to the polymer (A) and the polymer (B), the liquid crystal aligning agent of the present invention may contain other polymers. Other types of polymers include polyester, polyamide, polyurea, polyorganosiloxane, cellulose derivatives, polyacetal, polystyrene or its derivatives, poly(styrene-phenylmaleic acid) imide) derivatives, poly(meth)acrylates, etc.
液晶配向劑,為用於製作液晶配向膜者,就形成均勻之薄膜的觀點,係採取塗佈液之形態。本發明之液晶配向劑中,亦較佳為含有前述聚合物成分與有機溶劑之塗佈液。此時,液晶配向劑中之聚合物之濃度,可依所欲形成之塗膜的厚度之設定來適當變更。就形成均勻且無缺陷之塗膜的觀點,較佳為1質量%以上,就溶液之保存安定性的觀點,較佳為10質量%以下。特佳的聚合物之濃度為2~8質量%。The liquid crystal aligning agent is used in the production of a liquid crystal aligning film, and takes the form of a coating solution from the viewpoint of forming a uniform thin film. The liquid crystal aligning agent of the present invention is also preferably a coating liquid containing the aforementioned polymer component and an organic solvent. At this time, the concentration of the polymer in the liquid crystal aligning agent can be appropriately changed according to the setting of the thickness of the coating film to be formed. From the viewpoint of forming a uniform and defect-free coating film, it is preferably 1 mass % or more, and from the viewpoint of the storage stability of the solution, it is preferably 10 mass % or less. A particularly preferred polymer concentration is 2 to 8 mass %.
液晶配向劑中含有的有機溶劑,只要係均勻溶解聚合物成分者則無特殊限定。其具體例子,可列舉N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、N,N-二甲基乳醯胺、N-甲基-2-吡咯啶酮、N-乙基-2-吡咯啶酮、N-(n-丁基)-2-吡咯啶酮、N-(tert-丁基)-2-吡咯啶酮、N-(n-戊基)-2-吡咯啶酮、N-甲氧基丙基-2-吡咯啶酮、N-乙氧基乙基-2-吡咯啶酮、N-甲氧基丁基-2-吡咯啶酮、N-環己基-2-吡咯啶酮、二甲基亞碸、γ-丁內酯、γ-戊內酯、1,3-二甲基-2-咪唑啶酮、甲基乙基酮、環己酮、環戊酮、3-甲氧基-N,N-二甲基丙醯胺、3-丁氧基-N,N-二甲基丙醯胺(此等亦總稱為「良溶劑」)等。其中尤以N-甲基-2-吡咯啶酮、N-乙基-2-吡咯啶酮、3-甲氧基-N,N-二甲基丙醯胺、3-丁氧基-N,N-二甲基丙醯胺或γ-丁內酯為佳。良溶劑之含量,較佳為液晶配向劑中所含有的溶劑全體之20~99質量%、更佳為20~90質量%、特佳為30~80質量%。The organic solvent contained in the liquid crystal aligning agent is not particularly limited as long as it dissolves the polymer component uniformly. Specific examples thereof include N,N-dimethylformamide, N,N-dimethylacetamide, N,N-dimethyllactamide, N-methyl-2-pyrrolidone, N-Ethyl-2-pyrrolidone, N-(n-butyl)-2-pyrrolidone, N-(tert-butyl)-2-pyrrolidone, N-(n-pentyl)- 2-pyrrolidone, N-methoxypropyl-2-pyrrolidone, N-ethoxyethyl-2-pyrrolidone, N-methoxybutyl-2-pyrrolidone, N- Cyclohexyl-2-pyrrolidone, dimethylsulfoxide, γ-butyrolactone, γ-valerolactone, 1,3-dimethyl-2-imidazolidinone, methyl ethyl ketone, cyclohexanone , cyclopentanone, 3-methoxy-N,N-dimethylpropionamide, 3-butoxy-N,N-dimethylpropionamide (these are also collectively referred to as "good solvents"), etc. . Among them, N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, 3-methoxy-N,N-dimethylpropionamide, 3-butoxy-N, N-dimethylpropionamide or γ-butyrolactone is preferred. The content of the good solvent is preferably 20 to 99% by mass, more preferably 20 to 90% by mass, and particularly preferably 30 to 80% by mass of the entire solvent contained in the liquid crystal aligning agent.
又,液晶配向劑中所含有的有機溶劑,較佳為使用於上述溶劑以外合併使用了提高塗佈液晶配向劑時之塗佈性或塗膜之表面平滑性的溶劑(亦稱為不良溶劑)之混合溶劑。合併使用之有機溶劑的具體例子如下述,但不限定於此等。In addition, the organic solvent contained in the liquid crystal aligning agent is preferably a solvent (also referred to as a poor solvent) that is used in combination with the above-mentioned solvents to improve the coatability or the surface smoothness of the coating film when coating the liquid crystal aligning agent. the mixed solvent. Specific examples of the organic solvent used in combination are as follows, but are not limited thereto.
例如,可列舉二異丙基醚、二異丁基醚、二異丁基甲醇(2,6-二甲基-4-庚醇)、乙二醇二甲基醚、乙二醇二乙基醚、乙二醇二丁基醚、1,2-丁氧基乙烷、二乙二醇二甲基醚、二乙二醇二乙基醚、4-羥基-4-甲基-2-戊酮、二乙二醇甲基乙基醚、二乙二醇二丁基醚、乙酸3-乙氧基丁酯、乙酸1-甲基戊酯、乙酸2-乙基丁酯、乙酸2-乙基己酯、乙二醇單乙酸酯、乙二醇二乙酸酯、碳酸丙烯酯、碳酸伸乙酯、乙二醇單丁基醚、乙二醇單異戊基醚、乙二醇單己基醚、丙二醇單丁基醚、1-(2-丁氧基乙氧基)-2-丙醇、2-(2-丁氧基乙氧基)-1-丙醇、丙二醇單甲基醚乙酸酯、二丙二醇單甲基醚、二丙二醇單乙基醚、二丙二醇二甲基醚、乙二醇單丁基醚乙酸酯、二乙二醇單乙基醚乙酸酯、二乙二醇單丁基醚乙酸酯、乙酸2-(2-乙氧基乙氧基)乙酯、二乙二醇乙酸酯、丙二醇二乙酸酯、乙酸n-丁酯、乙酸丙二醇單乙基醚、3-甲氧基丙酸甲酯、3-乙氧基丙酸乙酯、3-甲氧基丙酸乙酯、3-甲氧基丙酸丙酯、3-甲氧基丙酸丁酯、乳酸n-丁酯、乳酸異戊酯、二乙二醇單乙基醚、二異丁基酮(2,6-二甲基-4-庚酮)等。For example, diisopropyl ether, diisobutyl ether, diisobutyl methanol (2,6-dimethyl-4-heptanol), ethylene glycol dimethyl ether, ethylene glycol diethyl ether, ethylene glycol dibutyl ether, 1,2-butoxyethane, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, 4-hydroxy-4-methyl-2-pentane Ketone, Diethylene Glycol Methyl Ether, Diethylene Glycol Dibutyl Ether, 3-Ethoxybutyl Acetate, 1-Methyl Amyl Acetate, 2-Ethyl Butyl Acetate, 2-Ethyl Acetate Ethyl hexyl ester, ethylene glycol monoacetate, ethylene glycol diacetate, propylene carbonate, ethylene carbonate, ethylene glycol monobutyl ether, ethylene glycol monoisoamyl ether, ethylene glycol mono Hexyl ether, propylene glycol monobutyl ether, 1-(2-butoxyethoxy)-2-propanol, 2-(2-butoxyethoxy)-1-propanol, propylene glycol monomethyl ether Acetate, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, dipropylene glycol dimethyl ether, ethylene glycol monobutyl ether acetate, diethylene glycol monoethyl ether acetate, diethylene glycol Glycol monobutyl ether acetate, 2-(2-ethoxyethoxy)ethyl acetate, diethylene glycol acetate, propylene glycol diacetate, n-butyl acetate, propylene glycol monoethyl acetate base ether, methyl 3-methoxypropionate, ethyl 3-ethoxypropionate, ethyl 3-methoxypropionate, propyl 3-methoxypropionate, 3-methoxypropionic acid Butyl ester, n-butyl lactate, isoamyl lactate, diethylene glycol monoethyl ether, diisobutyl ketone (2,6-dimethyl-4-heptanone), etc.
其中尤佳為二異丁基甲醇、丙二醇單丁基醚、丙二醇二乙酸酯、二乙二醇二乙基醚、二丙二醇單甲基醚、二丙二醇二甲基醚、4-羥基-4-甲基-2-戊酮、乙二醇單丁基醚、乙二醇單丁基醚乙酸酯,或二異丁基酮。Among them, diisobutylmethanol, propylene glycol monobutyl ether, propylene glycol diacetate, diethylene glycol diethyl ether, dipropylene glycol monomethyl ether, dipropylene glycol dimethyl ether, 4-hydroxy-4 - methyl-2-pentanone, ethylene glycol monobutyl ether, ethylene glycol monobutyl ether acetate, or diisobutyl ketone.
良溶劑與不良溶劑之較佳的溶劑之組合,可列舉N-甲基-2-吡咯啶酮與乙二醇單丁基醚、N-甲基-2-吡咯啶酮與γ-丁內酯與乙二醇單丁基醚、N-甲基-2-吡咯啶酮與γ-丁內酯與丙二醇單丁基醚、N-乙基-2-吡咯啶酮與丙二醇單丁基醚、N-甲基-2-吡咯啶酮與γ-丁內酯與4-羥基-4-甲基-2-戊酮與二乙二醇二乙基醚、N-甲基-2-吡咯啶酮與γ-丁內酯與丙二醇單丁基醚與2,6-二甲基-4-庚酮、N-甲基-2-吡咯啶酮與γ-丁內酯與丙二醇單丁基醚與二異丙基醚、N-甲基-2-吡咯啶酮與γ-丁內酯與丙二醇單丁基醚與2,6-二甲基-4-庚醇、N-甲基-2-吡咯啶酮與γ-丁內酯與二丙二醇二甲基醚、N-甲基-2-吡咯啶酮與丙二醇單丁基醚與二丙二醇二甲基醚等。不良溶劑之含量,較佳為液晶配向劑中所含有的溶劑全體之1~80質量%、更佳為10~80質量%、特佳為20~70質量%。不良溶劑之種類及含量,係依液晶配向劑之塗佈裝置、塗佈條件、塗佈環境等而適當選擇。A preferable combination of a good solvent and a poor solvent can include N-methyl-2-pyrrolidone and ethylene glycol monobutyl ether, N-methyl-2-pyrrolidone and γ-butyrolactone With ethylene glycol monobutyl ether, N-methyl-2-pyrrolidone and γ-butyrolactone and propylene glycol monobutyl ether, N-ethyl-2-pyrrolidone and propylene glycol monobutyl ether, N -Methyl-2-pyrrolidone with γ-butyrolactone with 4-hydroxy-4-methyl-2-pentanone with diethylene glycol diethyl ether, N-methyl-2-pyrrolidone with γ-Butyrolactone and propylene glycol monobutyl ether and 2,6-dimethyl-4-heptanone, N-methyl-2-pyrrolidone and γ-butyrolactone and propylene glycol monobutyl ether and diiso Propyl ether, N-methyl-2-pyrrolidone with γ-butyrolactone and propylene glycol monobutyl ether with 2,6-dimethyl-4-heptanol, N-methyl-2-pyrrolidone With γ-butyrolactone and dipropylene glycol dimethyl ether, N-methyl-2-pyrrolidone and propylene glycol monobutyl ether and dipropylene glycol dimethyl ether, etc. The content of the poor solvent is preferably 1 to 80% by mass, more preferably 10 to 80% by mass, and particularly preferably 20 to 70% by mass of the entire solvent contained in the liquid crystal aligning agent. The type and content of the poor solvent are appropriately selected according to the coating apparatus, coating conditions, coating environment and the like of the liquid crystal alignment agent.
本發明之液晶配向劑,亦可追加含有聚合物成分及有機溶劑以外之成分(以下亦稱為添加劑成分)。如此的添加劑成分,可列舉用以提高液晶配向膜與基板之密著性或液晶配向膜與密封劑之密著性的密著助劑、用以提高液晶配向膜之強度的化合物(以下亦稱為交聯性化合物)、用以促進醯亞胺化之化合物、用以調整液晶配向膜之介電率或電阻的介電體或導電物質等。The liquid crystal aligning agent of the present invention may additionally contain components other than the polymer component and the organic solvent (hereinafter also referred to as additive components). Such additive components include adhesion aids for improving the adhesion between the liquid crystal alignment film and the substrate or adhesion between the liquid crystal alignment film and the sealant, and compounds for improving the strength of the liquid crystal alignment film (hereinafter also referred to as It is a cross-linking compound), a compound for promoting imidization, a dielectric or conductive substance for adjusting the permittivity or resistance of the liquid crystal alignment film, and the like.
作為前述交聯性化合物,就對AC殘像展現良好之耐性,膜強度之改善為高的觀點,亦可為具有選自由環氧乙烷基、氧雜環丁烷基、保護異氰酸酯基、保護異硫氰酸酯基、包含噁唑啉環結構之基、包含米氏酸(Meldrum’s acid)結構之基、環碳酸酯基,及式(d)表示之基所成之群的至少1種基之化合物,或選自下述式(e)表示之化合物的化合物(以下,亦將此等總稱為化合物(C))。The above-mentioned crosslinkable compound may have a compound selected from the group consisting of ethylene oxide group, oxetanyl group, protected isocyanate group, protection Isothiocyanate group, group containing oxazoline ring structure, group containing Meldrum's acid structure, cyclic carbonate group, and at least one group of the group of groups represented by formula (d) The compound, or a compound selected from the compounds represented by the following formula (e) (hereinafter, these are also collectively referred to as compound (C)).
(R2 及R3 係分別獨立地為氫原子、碳數1~3之烷基或「*-CH2 -OH」。A表示具有芳香環之(m+n)價有機基。m表示1~6之整數,n表示0~4之整數。R表示氫原子或碳數1~5之烷基。上述A之芳香環上的氫原子,亦可經鹵素原子、碳數1~6之烷基、碳數2~6之烯基、碳數2~6之炔基、含有氟原子之碳數1~6之1價有機基等之1價有機基取代)。 (R 2 and R 3 are each independently a hydrogen atom, an alkyl group having 1 to 3 carbon atoms, or "*-CH 2 -OH". A represents an (m+n)-valent organic group having an aromatic ring. m represents 1 An integer of ~6, n represents an integer of 0 to 4. R represents a hydrogen atom or an alkyl group with 1 to 5 carbon atoms. The hydrogen atom on the aromatic ring of the above A can also be passed through a halogen atom or an alkane with 1 to 6 carbon atoms. substituted by monovalent organic groups such as alkenyl groups with 2 to 6 carbon atoms, alkynyl groups with 2 to 6 carbon atoms, and monovalent organic groups with 1 to 6 carbon atoms containing fluorine atoms).
具有環氧乙烷基之化合物之具體例子,可列舉日本特開平10-338880號公報之段落[0037]記載之化合物,或國際公開第2017/170483號記載之骨架中具備三嗪環之化合物等之具有2個以上之環氧乙烷基的化合物。此等之中,亦可為N,N,N’,N’-四環氧丙基-m-二甲苯二胺、1,3-雙(N,N-二環氧丙基胺基甲基)環己烷、N,N,N’,N’-四環氧丙基-4、4’-二胺基二苯基甲烷、N,N,N’,N’-四環氧丙基-p-苯二胺、下述式(r-1)~(r-3)表示之化合物等之含有氮原子之化合物。Specific examples of the compound having an oxirane group include the compound described in paragraph [0037] of JP-A No. 10-338880, the compound having a triazine ring in the skeleton described in International Publication No. 2017/170483, and the like. A compound having two or more oxirane groups. Among these, N,N,N',N'-tetraglycidyl-m-xylenediamine, 1,3-bis(N,N-diglycidylaminomethyl) ) cyclohexane, N,N,N',N'-tetraglycidyl-4, 4'-diaminodiphenylmethane, N,N,N',N'-tetraglycidyl- Nitrogen-containing compounds such as p-phenylenediamine and compounds represented by the following formulae (r-1) to (r-3).
具有氧雜環丁烷基之化合物之具體例子,可列舉國際公開第2011/132751號之段落[0170]~[0175]記載之具有2個以上的氧雜環丁烷基之化合物等。Specific examples of the compound having an oxetanyl group include compounds having two or more oxetanyl groups described in paragraphs [0170] to [0175] of International Publication No. WO 2011/132751.
具有保護異氰酸酯基之化合物之具體例子,可列舉日本特開2014-224978號公報之段落[0046]~[0047]記載之具有2個以上的保護異氰酸酯基之化合物、國際公開第2015/141598號之段落[0119]~[0120]記載之具有3個以上的保護異氰酸酯基之化合物等,亦可為下述式(bi-1)~(bi-3)表示之化合物。Specific examples of the compound having a protected isocyanate group include the compounds having two or more protected isocyanate groups described in paragraphs [0046] to [0047] of JP-A No. 2014-224978, and those described in International Publication No. 2015/141598. The compound etc. which have three or more protected isocyanate groups described in paragraphs [0119] to [0120] may also be compounds represented by the following formulae (bi-1) to (bi-3).
具有保護異硫氰酸酯基之化合物之具體例子,可列舉日本特開2016-200798號公報記載之具有2個以上的保護異硫氰酸酯基之化合物。As a specific example of the compound which has a protected isothiocyanate group, the compound which has two or more protected isothiocyanate groups described in Unexamined-Japanese-Patent No. 2016-200798 is mentioned.
具有包含噁唑啉環結構之基的化合物之具體例子,可列舉日本特開2007-286597號公報之段落[0115]記載之包含2個以上的噁唑啉環結構之化合物。As a specific example of the compound which has a group containing an oxazoline ring structure, the compound containing two or more oxazoline ring structures described in the paragraph [0115] of Unexamined-Japanese-Patent No. 2007-286597 is mentioned.
具有包含米氏酸結構之基的化合物之具體例子,可列舉國際公開第2012/091088號記載之具有2個以上的米氏酸結構之化合物。As a specific example of the compound which has a group containing a Michaelis acid structure, the compound which has two or more Michaelis acid structures described in International Publication No. 2012/091088 can be mentioned.
具有環碳酸酯基之化合物之具體例子,可列舉國際公開第2011/155577號記載之化合物。Specific examples of the compound having a cyclocarbonate group include the compound described in International Publication No. 2011/155577.
前述式(d)表示之基的R2 、R3 之碳數1~3之烷基,可列舉甲基、乙基、丙基等。 The alkyl group having 1 to 3 carbon atoms in R 2 and R 3 of the group represented by the aforementioned formula (d) includes a methyl group, an ethyl group, a propyl group, and the like.
具有前述式(d)表示之基的化合物之具體例子,可列舉國際公開第2015/072554號或日本特開2016-118753號公報之段落[0058]記載之具有2個以上的前述式(d)表示之基的化合物、日本特開2016-200798號公報記載之化合物等,亦可為下述式(hd-1)~(hd-8)表示之化合物。Specific examples of the compound having a group represented by the aforementioned formula (d) include two or more of the aforementioned formula (d) described in paragraph [0058] of International Publication No. WO 2015/072554 or JP-A No. 2016-118753 The compound represented by the group, the compound described in JP 2016-200798 A, and the like may also be compounds represented by the following formulae (hd-1) to (hd-8).
前述式(e)之A中的具有芳香環之(m+n)價有機基,可列舉碳數6~30之(m+n)價之芳香族烴基、碳數6~30之芳香族烴基直接或透過連結基而鍵結之(m+n)價有機基、具有芳香族雜環之(m+n)價基。前述芳香族烴,例如可列舉苯、萘等。芳香族雜環,例如可列舉吡咯環、咪唑環、吡唑環、吡啶環、嘧啶環、喹啉環、異喹啉環、咔唑環、嗒嗪環、吡嗪環、苯并咪唑環、吲哚環、喹噁啉環、吖啶環等。前述連結基,可列舉碳數1~10之伸烷基、-NR-(R表示氫原子或碳數1~5之烷基)、由前述伸烷基去除一個氫原子而得之基、2價或3價之環己烷環等。再者,前述伸烷基之任意氫原子,亦可經氟原子或三氟甲基等之有機基取代。若列舉前述式(e)表示之化合物的具體例子,可列舉國際公開第2010/074269號記載之化合物、下述式(e-1)~(e-10)表示之化合物。The (m+n)-valent organic group having an aromatic ring in A of the aforementioned formula (e) includes an (m+n)-valent aromatic hydrocarbon group having 6 to 30 carbon atoms, and an aromatic hydrocarbon group having 6 to 30 carbon atoms. (m+n)-valent organic group directly or via a linking group, and (m+n)-valent group having an aromatic heterocycle. As said aromatic hydrocarbon, benzene, naphthalene, etc. are mentioned, for example. Aromatic heterocycles include, for example, pyrrole rings, imidazole rings, pyrazole rings, pyridine rings, pyrimidine rings, quinoline rings, isoquinoline rings, carbazole rings, pyrazine rings, pyrazine rings, benzimidazole rings, Indole ring, quinoxaline ring, acridine ring, etc. The aforementioned linking group includes an alkylene group having 1 to 10 carbon atoms, -NR- (R represents a hydrogen atom or an alkyl group having 1 to 5 carbon atoms), a group obtained by removing one hydrogen atom from the aforementioned alkylene group, and 2 Valence or trivalent cyclohexane ring, etc. Furthermore, any hydrogen atom of the aforementioned alkylene group may be substituted with an organic group such as a fluorine atom or a trifluoromethyl group. Specific examples of the compound represented by the aforementioned formula (e) include the compound described in International Publication No. 2010/074269 and the compounds represented by the following formulae (e-1) to (e-10).
上述化合物為交聯性化合物之一例,不限定於此等。例如,可列舉國際公開第2015/060357號之53頁[0105]~55頁[0116]揭示的上述以外之成分等。又,交聯性化合物亦可組合2種以上。The above-mentioned compound is an example of a crosslinkable compound, and is not limited to these. For example, components other than the above-mentioned components disclosed in WO 2015/060357 No. 53 [0105] to 55 [0116] can be mentioned. Moreover, you may combine 2 or more types of crosslinkable compounds.
本發明之液晶配向劑中,交聯性化合物之含量,相對於液晶配向劑中所含有的聚合物成分100質量份而言,較佳為0.5~20質量份,就交聯反應進行,且對AC殘像展現良好之耐性的觀點,更佳為1~15質量份。In the liquid crystal aligning agent of the present invention, the content of the crosslinkable compound is preferably 0.5 to 20 parts by mass relative to 100 parts by mass of the polymer component contained in the liquid crystal aligning agent, and the crosslinking reaction is carried out, and the From the viewpoint of showing good resistance to AC afterimages, it is more preferably 1 to 15 parts by mass.
前述密著助劑,例如可列舉3-胺基丙基三甲氧基矽烷、3-胺基丙基三乙氧基矽烷、3-胺基丙基二乙氧基甲基矽烷、2-胺基丙基三甲氧基矽烷、2-胺基丙基三乙氧基矽烷、N-(2-胺基乙基)-3-胺基丙基三甲氧基矽烷、N-(2-胺基乙基)-3-胺基丙基甲基二甲氧基矽烷、3-脲基丙基三甲氧基矽烷、3-脲基丙基三乙氧基矽烷、N-乙氧基羰基-3-胺基丙基三甲氧基矽烷、N-乙氧基羰基-3-胺基丙基三乙氧基矽烷、N-三乙氧基矽烷基丙基三乙三胺、N-三甲氧基矽烷基丙基三乙三胺、10-三甲氧基矽烷基-1,4,7-三氮雜癸烷、10-三乙氧基矽烷基-1,4,7-三氮雜癸烷、9-三甲氧基矽烷基-3,6-二氮雜壬基乙酸酯、9-三乙氧基矽烷基-3,6-二氮雜壬基乙酸酯、N-苄基-3-胺基丙基三甲氧基矽烷、N-苄基-3-胺基丙基三乙氧基矽烷、N-苯基-3-胺基丙基三甲氧基矽烷、N-苯基-3-胺基丙基三乙氧基矽烷、N-雙(氧基伸乙基)-3-胺基丙基三甲氧基矽烷、N-雙(氧基伸乙基)-3-胺基丙基三乙氧基矽烷、乙烯基三甲氧基矽烷、乙烯基三乙氧基矽烷、2-(3,4-環氧基環己基)乙基三甲氧基矽烷、3-環氧丙氧基丙基甲基二甲氧基矽烷、3-環氧丙氧基丙基三甲氧基矽烷、3-環氧丙氧基丙基甲基二乙氧基矽烷、3-環氧丙氧基丙基三乙氧基矽烷、p-苯乙烯基三甲氧基矽烷、3-甲基丙烯醯氧基丙基甲基二甲氧基矽烷、3-甲基丙烯醯氧基丙基三甲氧基矽烷、3-甲基丙烯醯氧基丙基甲基二乙氧基矽烷、3-甲基丙烯醯氧基丙基三乙氧基矽烷、3-丙烯醯氧基丙基三甲氧基矽烷、參-(三甲氧基矽烷基丙基)異三聚氰酸酯、3-巰基丙基甲基二甲氧基矽烷、3-巰基丙基三甲氧基矽烷、3-異氰酸酯丙基三乙氧基矽烷等之矽烷偶合劑。使用矽烷偶合劑時,就對AC殘像展現良好之耐性的觀點,相對於液晶配向劑中所含有的聚合物成分100質量份而言,較佳為0.1~30質量份、更佳為0.1~20質量份。Examples of the aforementioned adhesion aid include 3-aminopropyltrimethoxysilane, 3-aminopropyltriethoxysilane, 3-aminopropyldiethoxymethylsilane, 2-aminopropyltriethoxysilane, and 2-aminopropyltriethoxysilane. Propyltrimethoxysilane, 2-aminopropyltriethoxysilane, N-(2-aminoethyl)-3-aminopropyltrimethoxysilane, N-(2-aminoethyl) )-3-aminopropylmethyldimethoxysilane, 3-ureidopropyltrimethoxysilane, 3-ureidopropyltriethoxysilane, N-ethoxycarbonyl-3-amino Propyltrimethoxysilane, N-ethoxycarbonyl-3-aminopropyltriethoxysilane, N-triethoxysilylpropyltriethylenetriamine, N-trimethoxysilylpropyl Triethylenetriamine, 10-trimethoxysilyl-1,4,7-triazadecane, 10-triethoxysilyl-1,4,7-triazadecane, 9-trimethoxysilyl Silyl-3,6-diazanonyl acetate, 9-triethoxysilyl-3,6-diazanonyl acetate, N-benzyl-3-aminopropyl Trimethoxysilane, N-benzyl-3-aminopropyltriethoxysilane, N-phenyl-3-aminopropyltrimethoxysilane, N-phenyl-3-aminopropyltrimethoxysilane Ethoxysilane, N-bis(oxyethylidene)-3-aminopropyltrimethoxysilane, N-bis(oxyethylidene)-3-aminopropyltriethoxysilane, vinyl Trimethoxysilane, vinyltriethoxysilane, 2-(3,4-epoxycyclohexyl)ethyltrimethoxysilane, 3-glycidoxypropylmethyldimethoxysilane, 3-glycidoxypropyltrimethoxysilane, 3-glycidoxypropylmethyldiethoxysilane, 3-glycidoxypropyltriethoxysilane, p-styrene trimethoxysilane, 3-methacryloyloxypropylmethyldimethoxysilane, 3-methacryloyloxypropyltrimethoxysilane, 3-methacryloyloxypropylmethyl Diethoxysilane, 3-methacryloyloxypropyltriethoxysilane, 3-acryloyloxypropyltrimethoxysilane, para-(trimethoxysilylpropyl)heterotrimer Silane coupling agent of cyanate ester, 3-mercaptopropylmethyldimethoxysilane, 3-mercaptopropyltrimethoxysilane, 3-isocyanatopropyltriethoxysilane, etc. When a silane coupling agent is used, from the viewpoint of exhibiting good resistance to AC afterimages, it is preferably 0.1-30 parts by mass, more preferably 0.1-30 parts by mass with respect to 100 parts by mass of the polymer component contained in the liquid crystal aligning agent 20 parts by mass.
用以促進上述醯亞胺化之化合物,較佳為具有鹼性部位(例:一級胺基、脂肪族雜環(例:吡咯啶骨架)、芳香族雜環(例:咪唑環、吲哚環),或胍基等)之化合物(惟,上述交聯性化合物及密著助劑除外),或燒成時會產生上述鹼性部位之化合物。更佳為燒成時會產生上述鹼性部位之化合物,列舉較佳的具體例子時,可列舉胺基酸所具有的鹼性部位之一部分或全部被保護的胺基酸。上述胺基酸之具體例子,可列舉甘胺酸、丙胺酸、半胱胺酸、甲硫胺酸、天門冬醯胺、麩醯胺、纈胺酸、白胺酸、苯基丙胺酸、酪胺酸、色胺酸、脯胺酸、羥基脯胺酸、精胺酸、組胺酸、離胺酸、鳥胺酸。列舉用以促進醯亞胺化之化合物的更佳的具體例子時,可列舉N-α-(9-茀基甲氧基羰基)-N-τ-(tert-丁氧基羰基)-L-組胺酸。The compound for promoting the above imidization preferably has a basic moiety (eg, a primary amino group, an aliphatic heterocycle (eg, a pyrrolidine skeleton), an aromatic heterocycle (eg, an imidazole ring, an indole ring) ), or guanidino, etc.) compounds (except for the above-mentioned cross-linking compounds and adhesion assistants), or compounds that generate the above-mentioned basic sites during firing. More preferably, it is a compound which generates the above-mentioned basic moiety during calcination, and a preferable specific example is an amino acid in which a part or all of the basic moiety possessed by the amino acid is protected. Specific examples of the above amino acids include glycine, alanine, cysteine, methionine, aspartamine, glutamine, valine, leucine, phenylalanine, tyrosine Amino acid, tryptophan, proline, hydroxyproline, arginine, histidine, lysine, ornithine. More preferable specific examples of the compound for promoting imidization include N-α-(9-intenylmethoxycarbonyl)-N-τ-(tert-butoxycarbonyl)-L- histidine.
<液晶配向膜之製造方法> 使用本發明之液晶配向劑的液晶配向膜之製造方法,其特徵為依次進行:塗佈上述液晶配向劑之步驟(步驟(1))、將所塗佈之液晶配向劑燒成之步驟(步驟(2))、對步驟(2)所得之膜照射經偏光之紫外線之步驟(步驟(3))、將步驟(3)所得之膜於100℃以上,且高於步驟(2)之溫度下燒成之步驟(步驟(4))。<Manufacturing method of liquid crystal alignment film> The method for producing a liquid crystal alignment film using the liquid crystal alignment agent of the present invention is characterized by sequentially performing: the step of coating the liquid crystal alignment agent (step (1)), and the step of firing the applied liquid crystal alignment agent (step (1)) (2)), the step of irradiating the film obtained in step (2) with polarized ultraviolet rays (step (3)), and the film obtained in step (3) at a temperature above 100°C and higher than the temperature in step (2) The step of firing (step (4)).
<步驟(1)> 作為塗佈本發明所用的液晶配向劑之基板,只要係透明性高的基板則無特殊限定,亦可使用玻璃基板、氮化矽基板、壓克力基板或聚碳酸酯基板等之塑膠基板等。此時,若使用形成有用以驅動液晶之ITO電極等的基板時,就製程簡化之觀點而言較佳。又,於反射型之液晶顯示元件中,只要係僅於單側之基板,則亦可使用矽晶圓等之不透明之物,此時之電極,亦可使用鋁等之會反射光之材料。<Step (1)> The substrate on which the liquid crystal aligning agent used in the present invention is applied is not particularly limited as long as it is a substrate with high transparency, and plastic substrates such as glass substrates, silicon nitride substrates, acrylic substrates, and polycarbonate substrates can also be used. . In this case, it is preferable from the viewpoint of process simplification to use a substrate on which ITO electrodes or the like for driving the liquid crystal are formed. In addition, in the reflective liquid crystal display element, as long as the substrate is only on one side, an opaque material such as a silicon wafer can also be used, and a material that reflects light such as aluminum can also be used as the electrode at this time.
液晶配向劑之塗佈方法並無特殊限定,工業上一般而言為以網版印刷、平版印刷、柔版印刷或噴墨法等所進行之方法。其他之塗佈方法,係有浸漬法、輥塗佈器法、狹縫塗佈器法、旋轉器法或噴霧法等,可依目的來使用此等。The coating method of the liquid crystal alignment agent is not particularly limited, and generally in the industry, it is a method performed by screen printing, offset printing, flexographic printing, or inkjet method. Other coating methods include a dipping method, a roll coater method, a slit coater method, a spinner method, a spray method, and the like, and these can be used according to the purpose.
<步驟(2)> 步驟(2)為將塗佈於基板上之液晶配向劑燒成,而形成膜之步驟。將液晶配向劑塗佈於基板上之後,可藉由加熱板、熱循環型烘箱或IR(紅外線)型烘箱等之加熱手段,使溶劑蒸發,或進行聚合物中之醯胺酸或醯胺酸酯的熱醯亞胺化。塗佈本發明之液晶配向劑後之乾燥、燒成步驟,可選擇任意之溫度與時間,亦可進行複數次。燒成溫度例如可在40~150℃進行。就縮短製程之觀點,亦可於40~120℃進行。燒成時間並無特殊限定,可列舉1~10分鐘或1~5分鐘。進行聚合物中之醯胺酸或醯胺酸酯的熱醯亞胺化時,可在上述燒成步驟之後,進行例如於190~250℃或200~240℃之溫度範圍下燒成的步驟。燒成時間並無特殊限定,可列舉5~40分鐘或5~30分鐘的燒成時間。<Step (2)> Step (2) is a step of firing the liquid crystal aligning agent applied on the substrate to form a film. After the liquid crystal alignment agent is coated on the substrate, the solvent can be evaporated by heating means such as a heating plate, a thermal cycle oven or an IR (infrared) oven, or the amide acid or amide acid in the polymer can be evaporated. Thermal imidization of esters. The drying and firing steps after coating the liquid crystal aligning agent of the present invention may be performed at any temperature and time, and may be performed several times. The firing temperature can be performed at, for example, 40 to 150°C. From the viewpoint of shortening the process, it can also be performed at 40 to 120°C. The calcination time is not particularly limited, and 1 to 10 minutes or 1 to 5 minutes can be mentioned. When thermal imidization of the amide acid or amide ester in the polymer is performed, after the above-mentioned calcination step, a calcination step in a temperature range of, for example, 190 to 250°C or 200 to 240°C can be performed. The calcination time is not particularly limited, and a calcination time of 5 to 40 minutes or 5 to 30 minutes is exemplified.
<步驟(3)> 步驟(3)為對步驟(2)所得之膜照射經偏光之紫外線的步驟。紫外線之波長較佳為200~400nm,其中尤更佳為具有200~300nm之波長的紫外線。為了改善液晶配向性,亦可將塗膜有液晶配向膜之基板於50~250℃加熱,同時照射紫外線。又,前述紫外線之照射量較佳為1~10,000 mJ/cm2 、更佳為100~5,000mJ/cm2 。如此方式所製作之液晶配向膜,可使液晶分子朝一定方向安定地配向。<Step (3)> The step (3) is a step of irradiating the film obtained in the step (2) with polarized ultraviolet rays. The wavelength of the ultraviolet rays is preferably 200 to 400 nm, and especially, the ultraviolet rays having a wavelength of 200 to 300 nm are more preferable. In order to improve the alignment of the liquid crystal, the substrate coated with the liquid crystal alignment film can also be heated at 50-250° C. and irradiated with ultraviolet rays at the same time. In addition, the irradiation amount of the ultraviolet rays is preferably 1 to 10,000 mJ/cm 2 , more preferably 100 to 5,000 mJ/cm 2 . The liquid crystal alignment film produced in this way can stably align liquid crystal molecules in a certain direction.
經偏光之紫外線之消光比越高,可賦予越高之各向異性,故較佳。具體而言,經直線偏光之紫外線之消光比,較佳為10:1以上、更佳為20:1以上。The higher the extinction ratio of polarized ultraviolet rays, the higher the anisotropy can be imparted, so it is better. Specifically, the extinction ratio of linearly polarized ultraviolet rays is preferably 10:1 or more, more preferably 20:1 or more.
<步驟(4)> 步驟(4),為將步驟(3)所得之膜,於100℃以上且高於步驟(2)之溫度下燒成之步驟。燒成溫度只要係100℃以上且高於在步驟(2)之燒成溫度,則無特殊限定,較佳為150~300℃、更佳為150~250℃、又更佳為200~250℃。燒成時間較佳為5~120分鐘、更佳為5~60分鐘、又更佳為5~30分鐘。<Step (4)> The step (4) is a step of firing the film obtained in the step (3) at a temperature above 100° C. and higher than the temperature in the step (2). The firing temperature is not particularly limited as long as it is 100°C or higher and higher than the firing temperature in step (2), preferably 150 to 300°C, more preferably 150 to 250°C, and still more preferably 200 to 250°C . The firing time is preferably 5 to 120 minutes, more preferably 5 to 60 minutes, and still more preferably 5 to 30 minutes.
燒成後之液晶配向膜之厚度,過薄時,可能有液晶顯示元件之信賴性降低的情況,故較佳為5~300 nm、更佳為10~200nm。When the thickness of the liquid crystal alignment film after firing is too thin, the reliability of the liquid crystal display element may decrease, so it is preferably 5 to 300 nm, more preferably 10 to 200 nm.
進一步地,在進行前述步驟(3)或(4)之任一步驟後,亦可將所得之液晶配向膜,使用水或溶劑進行接觸處理。Further, after performing any one of the aforementioned steps (3) or (4), the obtained liquid crystal alignment film can also be subjected to a contact treatment with water or a solvent.
上述接觸處理所使用之溶劑,只要係會溶解藉由紫外線照射而由液晶配向膜所生成之分解物的溶劑,則無特殊限定。具體例子可列舉水、甲醇、乙醇、2-丙醇、丙酮、甲基乙基酮、1-甲氧基-2-丙醇、1-甲氧基-2-丙醇乙酸酯、丁基賽珞蘇、乳酸乙酯、乳酸甲酯、二丙酮醇、3-甲氧基丙酸甲酯、3-乙氧基丙酸乙酯、乙酸丙酯、乙酸丁酯或乙酸環己酯等。其中就通用性或溶劑之安全性的觀點,尤以水、2-丙醇、1-甲氧基-2-丙醇或乳酸乙酯為佳。更佳為水、1-甲氧基-2-丙醇或乳酸乙酯。溶劑可為1種、亦可組合2種以上。The solvent used for the above-mentioned contact treatment is not particularly limited as long as it dissolves the decomposed product generated by the liquid crystal alignment film by ultraviolet irradiation. Specific examples include water, methanol, ethanol, 2-propanol, acetone, methyl ethyl ketone, 1-methoxy-2-propanol, 1-methoxy-2-propanol acetate, butyl Celosul, ethyl lactate, methyl lactate, diacetone alcohol, methyl 3-methoxypropionate, ethyl 3-ethoxypropionate, propyl acetate, butyl acetate or cyclohexyl acetate, etc. Among them, water, 2-propanol, 1-methoxy-2-propanol, or ethyl lactate are particularly preferred from the viewpoint of versatility or safety of the solvent. More preferred is water, 1-methoxy-2-propanol or ethyl lactate. One type of solvent may be used, or two or more types may be combined.
上述之接觸處理,亦即以水或溶劑對照射過經偏光之紫外線之液晶配向膜的處理,可列舉浸漬處理或噴霧處理(亦稱為噴灑處理)。此等處理之處理時間,就有效率地溶解藉由紫外線而由液晶配向膜生成之分解物的觀點,較佳為10秒~1小時。其中尤佳為進行1~30分鐘浸漬處理。又,前述接觸處理時之溶劑,可為常溫亦可經加溫,較佳為10~80℃、更佳為20~50℃。此外,就分解物之溶解性的觀點,亦可依需要進行超音波處理等。The above-mentioned contact treatment, that is, the treatment of the liquid crystal alignment film irradiated with polarized ultraviolet rays with water or solvent, includes immersion treatment or spray treatment (also called spray treatment). The treatment time of these treatments is preferably 10 seconds to 1 hour from the viewpoint of efficiently dissolving the decomposed products generated from the liquid crystal alignment film by ultraviolet rays. Among them, immersion treatment for 1 to 30 minutes is particularly preferred. In addition, the solvent in the aforementioned contact treatment may be at room temperature or heated, preferably 10 to 80°C, more preferably 20 to 50°C. In addition, from the viewpoint of the solubility of the decomposition product, ultrasonic treatment and the like may be performed as necessary.
前述接觸處理之後,較佳藉由水、甲醇、乙醇、2-丙醇、丙酮或甲基乙基酮等之低沸點溶劑,進行清洗(亦稱為潤洗)或液晶配向膜之燒成。此時,可進行潤洗與燒成的任一方,或亦可進行兩方。燒成之溫度,較佳為150~300℃。其中尤佳為180~250℃。更佳為200~230℃。又,燒成之時間,較佳為10秒~30分鐘。其中尤以1~10分鐘為佳。After the aforementioned contact treatment, it is preferable to perform cleaning (also called rinsing) or firing of the liquid crystal alignment film with a low-boiling solvent such as water, methanol, ethanol, 2-propanol, acetone, or methyl ethyl ketone. At this time, either one of rinsing and firing may be performed, or both may be performed. The firing temperature is preferably 150 to 300°C. Among them, 180-250 degreeC is especially preferable. More preferably, it is 200-230 degreeC. In addition, the time for firing is preferably 10 seconds to 30 minutes. Among them, 1 to 10 minutes is the best.
本發明之液晶配向膜,適合作為IPS方式或FFS方式等之橫電場方式的液晶顯示元件之液晶配向膜,特別是有用於作為FFS方式之液晶顯示元件之液晶配向膜。液晶顯示元件,係得到附有由本發明之液晶配向劑所得之液晶配向膜之基板後,藉由已知之方法製作液晶晶胞,並使用該液晶晶胞得到。The liquid crystal alignment film of the present invention is suitable as a liquid crystal alignment film for a liquid crystal display element of a transverse electric field method such as an IPS method or an FFS method, and is particularly useful as a liquid crystal alignment film for a liquid crystal display element of the FFS method. The liquid crystal display element is obtained by producing a liquid crystal cell by a known method after obtaining a substrate with a liquid crystal alignment film obtained from the liquid crystal alignment agent of the present invention, and using the liquid crystal cell.
作為液晶晶胞之製作方法的一例,係以被動矩陣結構之液晶顯示元件為例來進行說明。再者,亦可為在構成影像顯示之各畫素部分設有TFT(Thin Film Transistor)等之切換元件的主動矩陣結構之液晶顯示元件。As an example of the manufacturing method of a liquid crystal cell, the liquid crystal display element of a passive matrix structure is demonstrated as an example. Furthermore, it can also be a liquid crystal display element of an active matrix structure in which switching elements such as TFT (Thin Film Transistor) are provided in each pixel portion constituting the image display.
具體而言,係準備透明的玻璃製之基板,於一方之基板上設置共同電極、於另一方之基板上設置節段電極(segment electrode)。此等之電極例如可為ITO電極,係經圖型化,使得可進行所期望之影像顯示。接著,於各基板之上設置絕緣膜,而被覆共同電極與節段電極。絕緣膜例如可為藉由溶膠-凝膠法所形成之SiO2 -TiO2 之膜。Specifically, a transparent glass substrate is prepared, a common electrode is provided on one substrate, and segment electrodes are provided on the other substrate. These electrodes can be, for example, ITO electrodes, which are patterned so that the desired image display can be performed. Next, an insulating film is provided on each substrate to cover the common electrode and the segment electrode. The insulating film may be, for example, a film of SiO 2 -TiO 2 formed by a sol-gel method.
接著,於各基板之上形成液晶配向膜,於一方之基板上,使另一方之基板以彼此的液晶配向膜面呈對向的方式進行疊合,將周邊以密封劑接著。為了控制基板間隙,通常於密封劑係預先混入間隙物(spacer),又,較佳為於未設置密封劑之面內部分,亦預先散佈基板間隙控制用之間隙物。於密封劑之一部分,係預先設置可由外部填充液晶之開口部。接著,通過設置於密封劑之開口部,於經2片基板與密封劑包圍的空間內注入液晶材料,之後,將該開口部以接著劑密封。注入可使用真空注入法、亦可使用在大氣中利用毛細管現象之方法。液晶材料可使用正型液晶材料或負型液晶材料之任意者。接著,進行偏光板之設置。具體而言,係於2片基板之與液晶層相反側之面上,貼附一對偏光板。Next, a liquid crystal alignment film is formed on each of the substrates, and on one of the substrates, the other substrates are stacked so that the surfaces of the liquid crystal alignment films face each other, and the periphery is bonded with a sealant. In order to control the gap between the substrates, a spacer is usually mixed in the sealant in advance, and it is preferable that a spacer for controlling the gap between the substrates is also dispersed in advance in the in-plane portion where the sealant is not provided. In a part of the sealant, an opening part which can be filled with liquid crystal from the outside is provided in advance. Next, the liquid crystal material was injected into the space surrounded by the two substrates and the sealant through the opening provided in the sealant, and then the opening was sealed with the adhesive. For the injection, a vacuum injection method or a method utilizing capillary phenomenon in the atmosphere may be used. As the liquid crystal material, any one of a positive type liquid crystal material or a negative type liquid crystal material can be used. Next, set the polarizer. Specifically, a pair of polarizers are attached to the surface of the two substrates on the opposite side to the liquid crystal layer.
藉由使用本發明之製造方法,可抑制於IPS驅動方式或FFS驅動方式之液晶顯示元件中所產生的長期交流驅動所致之殘像。又,步驟(2)中,在於40~150℃之溫度範圍進行燒成後,藉由實施步驟(3),能夠以較以往更少的步驟數得到液晶配向膜。本發明之液晶配向劑,可特佳地使用於在步驟(2)中,於40~150℃之溫度範圍燒成後,包含實施步驟(3)之步驟的液晶配向膜之製造方法。 [實施例]By using the manufacturing method of the present invention, afterimages caused by long-term AC driving, which are generated in a liquid crystal display element of an IPS driving method or an FFS driving method, can be suppressed. Moreover, in step (2), after baking in the temperature range of 40-150 degreeC, by implementing step (3), a liquid crystal aligning film can be obtained with a smaller number of steps than in the past. The liquid crystal alignment agent of the present invention can be particularly preferably used in the manufacturing method of the liquid crystal alignment film including the step of implementing the step (3) after firing in the temperature range of 40-150°C in the step (2). [Example]
(溶劑) NMP:N-甲基-2-吡咯啶酮 BCS:丁基賽珞蘇 (二胺) DA-1~DA-9:分別以下述式(DA-1)~式(DA-9)表示之化合物 (四羧酸二酐) CA-1~CA-5:分別以下述式(CA-1)~式(CA-5)表示之化合物 (添加劑) C-1:2,2’-雙(4-羥基-3,5-二羥基甲基苯基)丙烷(下述式(C-1)表示之化合物) S-1:下述式(S-1)表示之化合物 F-1:下述式(F-1)表示之化合物(solvent) NMP: N-methyl-2-pyrrolidone BCS: Butyl Cyrus (diamine) DA-1 to DA-9: compounds represented by the following formulae (DA-1) to (DA-9), respectively (tetracarboxylic dianhydride) CA-1 to CA-5: compounds represented by the following formulae (CA-1) to (CA-5), respectively (additive) C-1: 2,2'-bis(4-hydroxy-3,5-dihydroxymethylphenyl)propane (compound represented by the following formula (C-1)) S-1: a compound represented by the following formula (S-1) F-1: a compound represented by the following formula (F-1)
(Fmoc表示9-茀基甲氧基羰基)。 (Fmoc represents 9-fenylmethoxycarbonyl).
<黏度之測定> 使用E型黏度計TVE-22H(東機產業公司製),以樣品量1.1mL、錐形轉子TE-1(1°34’、R24)、溫度25℃進行測定。<Measurement of viscosity> The measurement was performed using an E-type viscometer TVE-22H (manufactured by Toki Sangyo Co., Ltd.) with a sample volume of 1.1 mL, a conical rotor TE-1 (1°34', R24), and a temperature of 25°C.
<醯亞胺化率之測定> 將聚醯亞胺粉末20mg置入NMR樣品管(NMR取樣管標準品,φ5(草野科學公司製))中,添加重氫化二甲基亞碸(DMSO-d6,0.05%TMS(四甲基矽烷)混合品)(0.53mL),施加超音波使其完全溶解。將該溶液以NMR測定機(JNW-ECA500)(日本電子Datum公司製)測定500MHz之質子NMR。醯亞胺化率,係將源自醯亞胺化前後未變化之結構的質子決定為基準質子,使用該質子之波峰積分值,與於9.5ppm~10.0ppm附近出現的源自醯胺酸之NH基的質子波峰積分值,由下式求得。 醯亞胺化率(%)=(1-α・x/y)×100 上述式中,x為源自醯胺酸之NH基的質子波峰積分值、y為基準質子之波峰積分值、α為聚醯胺酸(醯亞胺化率為0%)的情況時,相對於醯胺酸之NH基質子1個而言,基準質子之個數比例。<Measurement of imidization rate> 20 mg of polyimide powder was placed in an NMR sample tube (NMR sample tube standard, φ5 (manufactured by Kusano Scientific Co., Ltd.)), and deuterated dimethylsulfite (DMSO-d6, 0.05% TMS (tetramethylsilane) was added. ) mixture) (0.53 mL), and ultrasonically applied to dissolve it completely. The solution was measured for proton NMR at 500 MHz with an NMR measuring machine (JNW-ECA500) (manufactured by JEOL Ltd.). The imidization rate is determined by determining the proton originating from the unchanged structure before and after imidization as the reference proton, and using the peak integration value of the proton, and the difference between the proton derived from amide acid appearing in the vicinity of 9.5ppm to 10.0ppm. The integral value of the proton peak of the NH group is obtained by the following formula. Imidization rate (%)=(1-α・x/y)×100 In the above formula, when x is the peak integration value of the proton derived from the NH group of the amide acid, y is the peak integration value of the reference proton, and α is the polyamide acid (the imidization rate is 0%), the relative For one NH proton of amide acid, the ratio of the number of reference protons.
[聚合物之合成例] <合成例1> 於附攪拌裝置及附氮導入管之200mL四口燒瓶中,量取DA-1 4.95g(20.3mmol)、DA-2 5.30g(18.0mmol),及DA-3 1.60g(6.75mmol),添加NMP,使濃度成為12質量%,一邊送入氮一邊攪拌使其溶解。一邊攪拌該二胺溶液,一邊添加CA-1 9.28g(41.4mmol),添加NMP,使濃度成為12質量%,於40℃攪拌24小時而得到聚醯胺酸溶液。 將所得到之聚醯胺酸溶液35g(8.9mmol)取至附攪拌裝置及附氮導入管之100mL四口燒瓶中,添加NMP 11.7g,攪拌30分鐘。對所得之聚醯胺酸溶液添加乙酸酐2.74g(與聚醯胺酸莫耳對比為3當量)、吡啶0.71g(與聚醯胺酸莫耳對比為等量),於50℃加熱3小時,進行化學醯亞胺化。在攪拌下將所得之反應液投入150mL之甲醇中,濾取所析出之沈澱物,實施同樣之操作2次藉以將樹脂粉末洗淨後,於60℃乾燥12小時,藉以得到聚醯亞胺樹脂粉末。該聚醯亞胺樹脂粉末之醯亞胺化率為75%。將所得之聚醯亞胺樹脂粉末3.60g取至100mL三角燒瓶中,添加NMP,使固體成分濃度成為12%,於70℃攪拌24小時使其溶解,而得到聚醯亞胺溶液(PI-1)。[Synthesis example of polymer] <Synthesis example 1> In a 200mL four-necked flask with a stirring device and a nitrogen introduction tube, measure DA-1 4.95g (20.3mmol), DA-2 5.30g (18.0mmol), and DA-3 1.60g (6.75mmol), add NMP was set to a concentration of 12 mass %, and was dissolved with stirring while feeding nitrogen. While stirring the diamine solution, 9.28 g (41.4 mmol) of CA-1 was added, and NMP was added to make the concentration 12% by mass, and the mixture was stirred at 40° C. for 24 hours to obtain a polyamic acid solution. 35 g (8.9 mmol) of the obtained polyamic acid solution was taken into a 100 mL four-neck flask with a stirring device and a nitrogen introduction tube, 11.7 g of NMP was added, and the mixture was stirred for 30 minutes. To the obtained polyamic acid solution, 2.74 g of acetic anhydride (3 equivalents compared to the polyamic acid molar) and 0.71 g of pyridine (equivalent to the polyamic acid moles) were added, and heated at 50°C for 3 hours , for chemical imidization. The obtained reaction solution was poured into 150 mL of methanol under stirring, the precipitated precipitate was collected by filtration, the same operation was performed twice to wash the resin powder, and then dried at 60° C. for 12 hours to obtain a polyimide resin powder. The imidization rate of the polyimide resin powder was 75%. 3.60 g of the obtained polyimide resin powder was taken into a 100-mL conical flask, NMP was added to make the solid content concentration 12%, and the solution was stirred at 70° C. for 24 hours to dissolve it to obtain a polyimide solution (PI-1 ).
<合成例2~10> 除了將所使用之單體種類及量變更為如下述表1所記載以外,係以與合成例1相同之手法得到聚醯亞胺溶液(PI-2)~(PI-10)。再者,表1中括弧內之數值,就四羧酸成分而言,係表示相對於合成所使用的四羧酸衍生物之合計量100莫耳份而言,各化合物之摻合比例(莫耳份),就二胺成分而言,係表示相對於合成所使用的二胺之合計量100莫耳份而言,各化合物之摻合比例(莫耳份)。就有機溶劑而言,係表示相對於聚醯亞胺溶液之調製所使用的有機溶劑之合計量100質量份而言,各有機溶劑之摻合比例(質量份)。 <合成例11> 於附攪拌裝置及附氮導入管之200mL四口燒瓶中,量取DA-7 3.37g(8.0mmol)、DA-8 2.39g(8.0mmol),及DA-9 4.78g(24.0mmol),添加NMP,使濃度成為12質量%,一邊送入氮一邊攪拌使其溶解。一邊攪拌該二胺溶液一邊添加CA-5 11.3g(38.5mmol),添加NMP,使濃度成為12質量%,於70℃攪拌24小時,得到聚醯胺酸溶液(PAA-1)。<Synthesis Examples 2 to 10> Polyimide solutions (PI-2) to (PI-10) were obtained in the same manner as in Synthesis Example 1, except that the types and amounts of the monomers used were changed as described in Table 1 below. In addition, the numerical values in parentheses in Table 1, in terms of tetracarboxylic acid components, represent the blending ratio (mol Ear part), with respect to a diamine component, shows the compounding ratio (mol part) of each compound with respect to 100 mol parts of the total amount of diamines used for synthesis. The organic solvent refers to the blending ratio (parts by mass) of each organic solvent with respect to 100 parts by mass of the total amount of organic solvents used for the preparation of the polyimide solution. <Synthesis Example 11> In a 200mL four-necked flask with a stirring device and a nitrogen introduction tube, measure 3.37g (8.0mmol) of DA-7, 2.39g (8.0mmol) of DA-8, and 4.78g (24.0mmol) of DA-9, add NMP was set to a concentration of 12 mass %, and was dissolved with stirring while feeding nitrogen. While stirring the diamine solution, 11.3 g (38.5 mmol) of CA-5 was added, and NMP was added to make the concentration 12% by mass, and the mixture was stirred at 70° C. for 24 hours to obtain a polyamic acid solution (PAA-1).
[液晶配向劑之調製] <比較例1> 於置入有攪拌子之樣品管中,添加合成例1所得到之聚醯亞胺溶液(PI-1)之溶液、NMP,及BCS,添加S-1、C-1及F-1,使得相對於聚合物固體成分100質量份而言,分別成為1質量份、10質量份、15質量份,攪拌30分鐘。攪拌後,得到聚醯亞胺溶液(PI-1)之固體成分濃度為6質量%,溶劑組成以質量比計為NMP:BCS=80:20之液晶配向劑(R1)。[Preparation of liquid crystal alignment agent] <Comparative Example 1> In a sample tube with a stirring bar, add the solution of the polyimide solution (PI-1) obtained in Synthesis Example 1, NMP, and BCS, and add S-1, C-1, and F-1, so that 1 mass part, 10 mass parts, and 15 mass parts with respect to 100 mass parts of polymer solid content, respectively, and it stirred for 30 minutes. After stirring, the solid content concentration of the polyimide solution (PI-1) was 6 mass %, and the solvent composition was a liquid crystal aligning agent (R1) of NMP:BCS=80:20 by mass ratio.
<比較例2~5、實施例1~12> 除了將所使用之聚合物成分變更為如下述表2所記載以外,係以與比較例1相同之手法,得到液晶配向劑(R2)~(R5)、(1)~(12)。表2中,括弧內之數值,就聚合物及添加劑而言係分別表示相對於液晶配向劑之調製所使用的聚合物成分之合計100質量份而言,各聚合物成分或添加劑之摻合比例(質量份)。就有機溶劑而言,係表示相對於液晶配向劑中之有機溶劑之合計量100質量份而言,各有機溶劑之摻合比例(質量份)。<Comparative Examples 2 to 5, Examples 1 to 12> Liquid crystal aligning agents (R2) to (R5) and (1) to (12) were obtained in the same manner as in Comparative Example 1, except that the polymer components used were changed as described in Table 2 below. In Table 2, the values in parentheses represent the blending ratio of each polymer component or additive with respect to the total 100 parts by mass of the polymer component used for the preparation of the liquid crystal aligning agent with respect to the polymer and the additive, respectively. (parts by mass). The organic solvent refers to the blending ratio (parts by mass) of each organic solvent with respect to 100 parts by mass of the total amount of organic solvents in the liquid crystal aligning agent.
使用如以上方式所得之液晶配向劑,由以下所示之程序製作FFS驅動液晶晶胞,進行特性評估。Using the liquid crystal aligning agent obtained as described above, an FFS-driven liquid crystal cell was produced by the procedure shown below, and characteristics were evaluated.
[FFS驅動液晶晶胞之構成] 邊緣電場切換(Fringe Field Switching:FFS)模式用之液晶晶胞,係以表面形成有由面形狀之共同電極-絕緣層-梳齒形狀之畫素電極所構成的FOP(Finger on Plate)電極層之第1玻璃基板,與表面具有高度3.5μm之柱狀間隙物且背面形成有用於抗靜電之ITO膜的第2玻璃基板為一組。上述之畫素電極,具有中央部分以內角160°彎曲之寬3μm的電極要素隔著6μm之間隔以呈平行的方式複數排列而得的梳齒形狀,1個畫素,係以連結複數個電極要素之彎曲部的線為界,而具有第1區域與第2區域。 再者,形成於第1玻璃基板之液晶配向膜,係以等分畫素彎曲部之內角的方向與液晶之配向方向直交的方式進行配向處理,形成於第2玻璃基板之液晶配向膜,係以製作液晶晶胞時第1基板上之液晶的配向方向與第2基板上之液晶的配向方向一致的方式進行配向處理。[The composition of the FFS-driven liquid crystal cell] The liquid crystal cell for fringe field switching (FFS) mode is formed on the surface with a FOP (Finger on Plate) electrode layer composed of a surface-shaped common electrode-insulating layer-comb-shaped pixel electrode The first glass substrate is a set of a second glass substrate having a columnar spacer having a height of 3.5 μm on the surface and an ITO film for antistatic formed on the rear surface. The above-mentioned pixel electrode has a comb-tooth shape in which electrode elements with a width of 3 μm bent at an inner angle of 160° in the central part are arranged in parallel with an interval of 6 μm in a comb-tooth shape, and one pixel is connected to a plurality of electrodes. The line of the curved part of an element is a boundary, and has a 1st area|region and a 2nd area|region. Furthermore, the liquid crystal alignment film formed on the first glass substrate is subjected to an alignment treatment in a manner that the direction that equally divides the inner angle of the curved portion of the pixel is perpendicular to the alignment direction of the liquid crystal, and the liquid crystal alignment film formed on the second glass substrate, The alignment treatment is performed so that the alignment direction of the liquid crystal on the first substrate and the alignment direction of the liquid crystal on the second substrate are consistent with each other when the liquid crystal cell is produced.
[液晶晶胞之製作] 於上述一組玻璃基板各自的表面,將經孔徑1.0μm之濾器過濾的液晶配向劑以旋轉塗佈進行塗佈,於80℃之加熱板上乾燥2分鐘。之後,對塗膜面,隔著偏光板照射消光比26:1之經直線偏光之波長254nm的紫外線150~350 mJ/cm2 ,接著於230℃之熱風循環式烘箱進行30分鐘燒成,得到2片附膜厚100nm之液晶配向膜之基板。 接著,對上述一組之附液晶配向膜之基板的一方印刷密封劑,將另一方之基板以液晶配向膜面呈對向的方式進行貼合,使密封劑(三井化學公司製 XN-1500T)硬化而製作空晶胞。對該空晶胞藉由減壓注入法,在常溫下真空注入液晶(默克公司製 MLC-3019),將注入口密封,得到FFS驅動液晶晶胞。之後,將所得之液晶晶胞於120℃加熱1小時(以下亦將本處理稱為ISO處理),放置一晩後使用於各評估。[Production of Liquid Crystal Cells] The liquid crystal aligning agent filtered through a filter with a pore size of 1.0 μm was applied on the surface of each of the above-mentioned glass substrates by spin coating, and dried on a hot plate at 80° C. for 2 minutes. After that, irradiate 150~350 mJ/cm 2 of linearly polarized ultraviolet rays with a wavelength of 254 nm with an extinction ratio of 26:1 to the surface of the coating film through a polarizing plate, and then bake in a hot air circulating oven at 230°C for 30 minutes to obtain 2 substrates with liquid crystal alignment film with a thickness of 100nm. Next, a sealant (XN-1500T manufactured by Mitsui Chemicals Co., Ltd.) was printed on one side of the above-mentioned substrates with liquid crystal alignment films, and the other substrates were bonded so that the surfaces of the liquid crystal alignment films faced each other. Empty unit cells are made by hardening. Liquid crystal (MLC-3019 manufactured by Merck & Co., Ltd.) was vacuum-injected into this empty cell at normal temperature by a reduced pressure injection method, and the injection port was sealed to obtain an FFS-driven liquid crystal cell. Then, the obtained liquid crystal cell was heated at 120 degreeC for 1 hour (this process is also called ISO process hereafter), and it was used for each evaluation after leaving to stand overnight.
<液晶配向性評估> 使用ISO處理前之液晶晶胞,將具有初期流動配向者定義為「不良」,及將無此情況者定義為「良好」,來進行評估。 <對比之面內均勻性評估> 使用SHINTECH公司製OPTIPRO-micro,進行液晶顯示元件之扭轉角之評估。將所製作之液晶晶胞設置於測定台,於電壓無施加之狀態,將第1畫素面內測定20點,算出標準偏差。評估係將扭轉角標準偏差為0.5以上者定義為「不良」、未達0.5者定義為「良好」來進行評估。<Evaluation of liquid crystal alignment> Using the liquid crystal cell before ISO treatment, those with initial flow alignment were defined as "poor", and those without this were defined as "good" for evaluation. <In-plane uniformity evaluation by comparison> The evaluation of the twist angle of the liquid crystal display element was performed using the OPTIPRO-micro manufactured by SHINTECH. The produced liquid crystal cell was placed on a measuring stage, and in a state in which no voltage was applied, 20 points were measured in the first pixel plane, and the standard deviation was calculated. In the evaluation system, those with a standard deviation of the torsion angle of 0.5 or more were defined as "poor", and those less than 0.5 were defined as "good" and evaluated.
<電壓保持率評估> 將上述所製作的液晶晶胞,使用東陽Technica公司製裝置,於60℃施加1V之電壓60微秒後,測定1,000毫秒後之電壓保持率。此時,電壓保持率維持90%以上時定義為「良好」、未達90%時定義為「不良」來進行評估。<Evaluation of voltage holding ratio> The liquid crystal cell produced above was applied with a voltage of 1 V at 60° C. for 60 microseconds using an apparatus manufactured by Toyo Technica, and then the voltage holding ratio after 1,000 milliseconds was measured. At this time, when the voltage holding ratio was maintained at 90% or more, it was defined as "good", and when it was less than 90%, it was defined as "bad" and evaluated.
<評估結果> 關於使用上述實施例1~12及比較例1~5所得到之液晶配向劑(1)~(12)、(R1)~(R5)所得之液晶顯示元件,將評估結果示於表3。<Evaluation results> The evaluation result is shown in Table 3 about the liquid crystal display element obtained using the liquid crystal aligning agent (1)-(12) and (R1)-(R5) obtained by the said Example 1-12 and the comparative example 1-5.
Claims (12)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020052727 | 2020-03-24 | ||
| JP2020-052727 | 2020-03-24 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW202146528A true TW202146528A (en) | 2021-12-16 |
| TWI881079B TWI881079B (en) | 2025-04-21 |
Family
ID=77891728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW110110143A TWI881079B (en) | 2020-03-24 | 2021-03-22 | Liquid crystal alignment agent for photo-alignment method, liquid crystal alignment film, and liquid crystal display element |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JP7623635B2 (en) |
| KR (1) | KR20220157403A (en) |
| CN (1) | CN115380243B (en) |
| TW (1) | TWI881079B (en) |
| WO (1) | WO2021193078A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240076516A (en) | 2022-11-22 | 2024-05-30 | 엘지디스플레이 주식회사 | Display device |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3893659B2 (en) | 1996-03-05 | 2007-03-14 | 日産化学工業株式会社 | Liquid crystal alignment treatment method |
| JP4779339B2 (en) * | 2003-11-05 | 2011-09-28 | Jnc株式会社 | Liquid crystal aligning agent and liquid crystal display element using the same |
| CN105754098B (en) | 2010-10-06 | 2018-05-18 | 株式会社日本显示器 | Composition for forming alignment film |
| WO2014080865A1 (en) * | 2012-11-21 | 2014-05-30 | Jsr株式会社 | Liquid crystal orientation agent, liquid crystal orientation membrane and method for manufacturing same, and liquid crystal display element |
| TWI513737B (en) * | 2013-11-29 | 2015-12-21 | Daxin Materials Corp | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display |
| US9650543B2 (en) * | 2014-03-18 | 2017-05-16 | Fuji Xerox Co., Ltd. | Polyimide precursor composition, method for manufacturing polyimide molded body, and polyimide molded body |
| JP6841069B2 (en) | 2016-04-28 | 2021-03-10 | Jsr株式会社 | Liquid crystal alignment agent, liquid crystal alignment film and its manufacturing method, and liquid crystal element |
| JP7287119B2 (en) * | 2018-06-01 | 2023-06-06 | Jnc株式会社 | Liquid crystal aligning agent for photo-alignment, liquid crystal alignment film and liquid crystal display element using the same |
| JP7392646B2 (en) | 2018-08-20 | 2023-12-06 | 日産化学株式会社 | Liquid crystal alignment agent, manufacturing method thereof, liquid crystal alignment film, and liquid crystal display element |
-
2021
- 2021-03-10 JP JP2022509897A patent/JP7623635B2/en active Active
- 2021-03-10 KR KR1020227033296A patent/KR20220157403A/en active Pending
- 2021-03-10 CN CN202180024468.2A patent/CN115380243B/en active Active
- 2021-03-10 WO PCT/JP2021/009665 patent/WO2021193078A1/en not_active Ceased
- 2021-03-22 TW TW110110143A patent/TWI881079B/en active
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2021193078A1 (en) | 2021-09-30 |
| KR20220157403A (en) | 2022-11-29 |
| WO2021193078A1 (en) | 2021-09-30 |
| CN115380243B (en) | 2025-04-15 |
| JP7623635B2 (en) | 2025-01-29 |
| TWI881079B (en) | 2025-04-21 |
| CN115380243A (en) | 2022-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2020158818A1 (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element using it | |
| JP2026004523A (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
| TWI848062B (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element using the same | |
| TWI864241B (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | |
| CN115380243B (en) | Liquid crystal alignment agent for photo-alignment method, liquid crystal alignment film, and liquid crystal display element | |
| WO2024219400A1 (en) | Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element | |
| WO2024219401A1 (en) | Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element | |
| TW202317740A (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
| TW202328291A (en) | Liquid crystal alignment agent, liquid crystal alignment film, liquid crystal display element, and compound | |
| WO2023068084A1 (en) | Liquid crystal alignment agent, liquid crystal alignment film, liquid crystal display element, compound and polymer | |
| TWI859005B (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | |
| TWI887964B (en) | Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element | |
| TW202037716A (en) | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element | |
| JP7694561B2 (en) | Novel diamine, polymer, liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element using the same | |
| JP7428138B2 (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | |
| JP7469736B2 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
| WO2026009864A1 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
| CN118725877A (en) | Liquid crystal alignment agent, liquid crystal alignment film, liquid crystal display element, and method for producing the same | |
| WO2025079671A1 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
| TW202227601A (en) | Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element |